cn reddy  cypress plc  zoominfocom d srinivasa reddy  wikipedia d srinivasa reddy from wikipedia the free encyclopedia jump to navigation search d srinivasa reddy born  april   age  andhra pradesh india residence pune maharashtra india nationality indian fields organic chemistry medicinal chemistry institutions dr reddys laboratories advinus therapeutics national chemical laboratory alma mater osmania university university of hyderabad indian institute of science university of chicago university of kansas doctoral advisor goverdhan mehta sergey a kozmin jeffrey aubé known for siliconswitch approach notable awards  central drug research institute research excellence award  crsi bronze medal  nasireliance industries platinum jubilee award  shanti swarup bhatnagar prize dumbala srinivasa reddy born  is an indian organic and medicinal chemist and a senior scientist at national chemical laboratory he is known for the application of siliconswitch approach a management protocol for treating diseases affecting the central nervous system in his researches and is a recipient of the bronze medal of the chemical research society of india nasireliance industries platinum jubilee award and the drug research excellence award of the central drug research institute the council of scientific and industrial research the apex agency of the government of india for scientific research awarded him the shanti swarup bhatnagar prize for science and technology one of the highest indian science awards in  for his contributions to chemical sciences contents  biography  legacy  awards and honors  see also  references  external links biographyedit national chemical laboratory born on  april  in the south indian state of andhra pradesh d srinivasa reddy graduated in chemistry in  from osmania university and completed his masters degree from the same institution in  enrolling for his doctoral studies under the guidance of goverdhan mehta a noted chemist and former vice chancellor of university of hyderabad he moved to indian institute of science when mehta took up the position as the head of the department of organic chemistry at iisc his phd came from hyderabad university in  and he proceeded to the us where he did his postdoctoral work at the laboratories of sergey a kozmin of the university of chicago and jeffrey aubé of university of kansas during – he started his career in  as a principal scientist at dr reddy’s laboratories and became a research investigator in  but a year later he moved to advinus therapeutics as the group leader of their discovery chemistry research wing in  he was promoted as the section head soon after he left for national chemical laboratory where he works as a senior scientist legacyedit reddys researches have been focused on total organic synthesis of molecules with a view to their applications in agricultural and medicinal uses he is credited with the total synthesis of over  agrochemicals which includes a mealy bugattracting sex pheromone that has reported use in crop protection he has also developed several other products that has potential uses as celladhesion inhibitors antibacterial antiinflammatory as well as anticancer agents and as insect repellents he employs the siliconswitch approach for developing drug strategies for diseases affecting the central nervous system and his work has assisted in the drug discovery for the treatment of some infectious diseases as well as diabetes his researches have been documented by way of a number of peerreviewed articles google scholar an online article repository of scientific articles has listed  of them respectively he has also applied for  patents based on his researches awards and honorsedit dr d srinivasa reddy of ncl receives the shanti swarup bhatnagar prize  group picture new delhi india reddy received the award for excellence in drug research of the central drug research institute in  and the scientist of the year award of the national chemical laboratory the same year he received three awards in  starting with the nasireliance industries platinum jubilee award followed by the bronze medal of the chemical research society of india the council of scientific and industrial research awarded him the shanti swarup bhatnagar prize one of the highest indian science awards also in  see alsoedit goverdhan mehta india portal chemistry portal referencesedit  brief profile of the awardee shanti swarup bhatnagar prize  retrieved november     a b research details national chemical laboratory    a b c ncl’s d srinivasa reddy has been selected for this year’s nasireliance industries platinum jubilee award times of india june     cdri award pdf central drug research institute    view bhatnagar awardees shanti swarup bhatnagar prize  retrieved november     a b biography pdf national chemical laboratory    reddy on csir pdf council of scientific and industrial research    professional experience national chemical laboratory    a b dr srinivasa reddy of csirncl bags the prestigious shanti swarup bhatnagar prize biospectrum september     on researchgate researchgate    on google scholar google scholar    list of patents google patents    n vasudevan gorakhnath r jachak d srinivasa reddy december  breaking and making of rings european journal of organic chemistry  – doiejoc   b seetharamsingh remya ramesh santoshkumar s dange pankaj v khairnar smita singhal dilip upadhyay sridhar veeraraghavan srikant viswanadha swaroop vakkalanka d srinivasa reddy october  design synthesis and identification of silicon incorporated oxazolidinone antibiotics with improved brain exposure acs med chem lett doiacsmedchemlettb   awards and recognition national chemical laboratory    chemical sciences council of scientific and industrial research   external linksedit d srinivasa reddy scientist profile one organic chemist one day   d srinivasa reddy various links new drug approvals   d srinivasa reddy various links all for drugs   d srinivasa reddy product linkssilico linezolid silinezolid nds  organic spectroscopy international   d srinivasa reddy personal profile linkedin   d srinivasa reddy personal profile researchgate   d srinivasa reddy personal profile facebook   d srinivasa reddy patent highlight new drug approvals   d srinivasa reddy various links one organic chemist one day   v t e recipients of shanti swarup bhatnagar prize for science and technology in chemical science recipients tuticorin raghavachari govindachari  asima chatterjee  s c bhattacharyya  b d tilak  sukh dev  sadhan basu  r c mehrotra  nanduri atchuta ramaiah  mushi santappa  c n r rao  a c jain  p t narasimhan  m m dhar  s v kessar  a p b sinha  m v george  h b mathur  u r ghatak  k nagarajan  d s bhakuni  animesh chakravorty  devadas devaprabhakara  mihir chowdhury  s ranganathan  girjesh govil  goverdhan mehta  d balasubramanian  b m deb  c l khetrapal  g s r subba rao  samaresh mitra  naba kishore ray  paramasivam natarajan  k j rao  p balaram  debashis mukherjee  kaushal kishore  srinivasan chandrasekaran  m k chaudhuri  b m choudary  n sathyamurthy  biman bagchi  j s yadav  sumit bhaduri  suryanarayanasastry ramasesha  s r gadre  t ramasami  e d jemmis  d d sarma  jayaraman chandrasekhar  k l sebastian  narayanan chandrakumar  mariappan periasamy  kankan bhattacharyya  adusumilli srikrishna  a r chakravarty  k n ganesh  ganesh prasad pandey  deb shankar ray  sourav pal  pradeep mathur  uday maitra  t k chandrashekar  murali sastry  t k chakraborty  santanu bhattacharya  s ramakrishnan  srinivasan sampath  k george thomas  amalendu chandra  a ajayghosh  thalappil pradeep  jarugu narasimha moorthy  charusita chakravarty  narayanaswamy jayaraman swapan kumar pati  sandeep verma  balasubramanian sundaram  garikapati narahari sastry  gangadhar j sanjayan  govindasamy mugesh  yamuna krishnan  kavirayani ramakrishna prasad  souvik maiti  pradyut ghosh  d srinivasa reddy  partha sarathi mukherjee  all the branches biological science chemical science engineering science mathematical science medical science physical science earth atmosphere ocean  planetary sciences retrieved from httpsenwikipediaorgwindexphptitledsrinivasareddyoldid categories recipients of the shanti swarup bhatnagar award in chemical science birthsindian scientific authorsliving peoplescientists from andhra pradeshosmania university alumniindian institute of science alumniuniversity of chicago alumniuniversity of kansas alumnithcentury indian inventorsalumni of the university of hyderabad navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view dr reddys laboratories  wikipedia dr reddys laboratories from wikipedia the free encyclopedia jump to navigation search rdy redirects here for the radar system see radar doppler multitarget dr reddys laboratories type public traded as nse drreddy bse  nyse rdy industry pharmaceuticals founded  founders kallam anji reddy headquarters hyderabad telangana india key people g v prasad ceo kallam satish reddy chairman revenue ₹ crore us billion  net income ₹ crore us million  total assets ₹ crore us billion  total equity ₹ crore us million  number of employees  april  website wwwdrreddyscom dr reddys laboratories is an indian multinational pharmaceutical company based in hyderabad telangana india the company was founded by anji reddy who previously worked in the mentor institute indian drugs and pharmaceuticals limited of hyderabad india dr reddys manufactures and markets a wide range of pharmaceuticals in india and overseas the company has over  medications  active pharmaceutical ingredients apis for drug manufacture diagnostic kits critical care and biotechnology products dr reddys began as a supplier to indian drug manufacturers but it soon started exporting to other lessregulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the us food and drug administration fda by the early s the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in moredeveloped economies this allowed their movement into regulated markets such as the us and europe in  dr reddy laboratories was listed among  of indias most trusted brands according to the brand trust report  a study conducted by trust research advisory a brand analytics company by  dr reddys had six fda plants producing active pharmaceutical ingredients in india and seven fdainspected and iso  quality and iso  environmental management certified plants making patientready medications – five of them in india and two in the uk in  the familycontrolled dr reddys denied that it was in talks to sell its generics business in india to us pharmaceutical giant pfizer which had been suing the company for alleged patent infringement after dr reddys announced that it intended to produce a generic version of atorvastatin marketed by pfizer as lipitor an anticholesterol medication reddys was already linked to uk pharmaceuticals multinational glaxo smithkline contents  company history  international expansion  new drug discovery  expansion and acquisition  american ipo and expansion into europe  global expansion  patientcentric initiatives  issues and recalls  drug discovery problems   recall   fda form   key people  key products  top active pharmaceutical ingredients  top brands by dr reddys  see also  references  external links company historyedit dr reddys originally launched in  producing active pharmaceutical ingredients in  reddys started operations on branded formulations within a year reddys had launched norilet the companys first recognized brand in india soon dr reddys obtained another success with omez its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the indian market at that time within a year reddys became the first indian company to export the active ingredients for pharmaceuticals to europe in  reddys started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products international expansionedit the companys first international move took it to russia in  there dr reddys formed a joint venture with the countrys biggest pharmaceuticals producer biomed they pulled out in  amid accusations of scandal involving a significant material loss due to the activities of moscows branch of reddys labs with the help of biomeds chief executive reddys sold the joint venture to the kremlinfriendly sistema group in  reddys entered into a joint venture in the middle east and created two formulation units there and in russia reddys exported bulk drugs to these formulation units which then converted them into finished products in  reddys started targeting the us generic market by building state of art manufacturing facilitycitation needed new drug discoveryedit biopharma finished dosage unit iii in hyderabad biopharma finished dosage unit i in hyderabad reddys path into new drug discovery involved targeting speciality generics products in western markets to create a foundation for drug discovery development of speciality generics was an important step for the companys growing interest in the development of new chemical entities the elements involved in creating a speciality generic such as innovation in the laboratory developing the compound and sending the sales team to the market are also stages in the development of a new specialty drug starting with speciality generics allowed the company to gain experience with those steps before moving on to creating brandnew drugs reddys also invested heavily in establishing rd labs and is the only indian company to have significant rd being undertaken overseas dr reddys research foundation was established in  and in order to do research in the area of new drug discovery at first the foundations drug research strategy revolved around searching for analogues focus has since changed to innovative rd hiring new scientists especially indian students studying abroad on doctoral and postdoctoral courses in  the foundation set up an american laboratory in atlanta dedicated to discovery and design of novel therapeutics the laboratory is called reddy us therapeutics inc rusti and its main aim is the discovery of nextgeneration drugs using genomics and proteomics reddys research thrust focused on large niche areas in western markets – anticancer antidiabetes cardiovascular and antiinfection drugscitation needed reddys international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities reddys merged cheminor drug limited cdl with the primary aim of supplying active pharmaceutical ingredients to the technically demanding markets of north america and europe this merger also gave reddys an entry into the valueadded generics business in the regulated markets of apis apis in medicine expansion and acquisitionedit by  reddys made the transition from being an api and bulk drug supplier to regulated markets like the usa and the uk and a branded formulations supplier in unregulated markets like india and russia into producing generics by filing an abbreviated new drug application anda in the usa the same year reddys outlicensed a molecule for clinical trials to novo nordisk a danish pharmaceutical company it strengthened its indian manufacturing operations by acquiring american remedies ltd in  this acquisition made reddy’s the third largest pharmaceutical company in india after ranbaxy and glaxo i ltd with a full spectrum of pharmaceutical products which included bulk drugs intermediates finished dosages chemical synthesis diagnostics and biotechnologycitation needed reddy’s started exploiting para  filing as a strategy in bringing new drugs to the market at a faster pace in  it submitted a para  application for omeprazole the drug that had been the cornerstone of its success in india in december  reddy’s had undertaken its first commercial launch of a generic product in the usa and its first product with market exclusivity was launched there in august  the same year it also became the first nonjapanese pharmaceutical company from the asiapacific region to obtain a new york stock exchange listing groundbreaking achievements for the indian pharmaceutical industrycitation needed in  reddy’s became the first indian company to launch the generic drug fluoxetine a generic version of eli lilly and company’s prozac with day market exclusivity in the usa prozac had sales in excess of  billion per year in the late s barr laboratories of the us obtained exclusivity for all of the approved dosage forms  mg  mg except one  mg which was obtained by reddy’s lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection the case to allow generic sales was heard twice by the federal circuit court and reddy’s won both hearings reddy’s generated nearly  million in revenue during the initial sixmonth exclusivity period with such high returns at stake reddy’s was gambling on the success of the litigation failure to win the case could have cost them millions of dollars depending on the length of the trial the fluoxetine marketing success was followed by the american launch of reddys housebranded ibuprofen tablets in   and  mg strengths in january  direct marketing under the reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable us generic business it was the first step in building reddy’s fullyfledged distribution network in the us marketcitation needed in  dr reddys laboratories bought the established brands of belgian drugmaker ucb sa in south asia for  billion rupees  million dr reddys laboratories also signed a licensing pact with xenoport for their experimental treatment to treat plaque psoriasis as per the agreement dr reddy’s will be granted exclusive us rights to develop and commercialize xp for all indications for an upfront payment of  million american ipo and expansion into europeedit in  reddy’s completed its us initial public offering of  million secured by american depositary receipts at that time the company also became listed on the new york stock exchange funds raised from the initial public offering helped reddy’s move into international production and take over technologybased companies in  reddy’s started its european operations by acquiring two pharmaceutical firms in the united kingdom the acquisition of bms laboratories and its wholly owned subsidiary meridian uk allowed reddy’s to expand geographically into the european market in  reddy’s also invested  million usd in equity capital into bio sciences ltd auriegene discovery technologies a contract research company was established as a fully owned subsidiary of reddy’s in  auriegenes objective was to gain experience in drug discovery through contract research for other pharmaceutical companies reddy’s entered into a venture investment agreement with icici bank an established indian banking company under the terms of the agreement icici venture agreed to fund the development registration and legal costs related to the commercialization of andas on a predetermined basis upon commercialization of these products dr reddys pays icici venture royalty on net sales for a period of  years global expansionedit the company elected to expand globally and acquired other entities in march  dr reddy’s acquired bms laboratories beverley and its wholly owned subsidiary meridian healthcare for  million euros these companies deal in oral solids liquids and packaging with manufacturing facilities in london and beverley in the uk recently dr reddy’s entered into an rd and commercialization agreement with argenta discovery ltd a private drug development company based in the uk for the treatment of chronic obstructive pulmonary disease copd dr reddy’s entered into a year agreement with rheoscience as of denmark for the joint development and commercialization of balaglitazone drf a molecule for the treatment of type diabetes rheoscience holds this product’s marketing rights for the european union and china while the rights for the us and the rest of the world will be held by dr reddy’s dr reddy’s conducted clinical trials of its cardiovascular drug rus  in belfast northern ireland in  the trials were conducted to study the safety and the pharmacokinetic profiles of the drug which is intended for the treatment of atherosclerosis a major cause of cardiovascular disorders dr reddy’s entered into a marketing agreement with eurodrug laboratories a pharmaceutical company based in netherlands for improving its product portfolio for respiratory diseases it introduced a secondgeneration xanthine bronchodilator doxofylline which is used for the treatment of asthma and copd patients in  reddy’s acquired trigenesis therapeutics inc a usbased private dermatology company this acquisition gave reddy’s access to proprietary products and technologies in the dermatology sector dr reddy’s para  application strategy for generic business received a severe setback when reddy’s lost the patent challenge in the case of pfizer’s drug norvasc amlodipine maleate a drug indicated for the treatment of hypertension and angina the cost involved in patent litigation as well as the unexpected loss of the patent challenge affected reddy’s plans to start speciality business in the us generic markets in march  dr reddy’s acquired betapharm arzneimittel gmbh from i for  million euros this is one of the largestever foreign acquisitions by an indian pharmaceutical company betapharm is germany’s fourthlargest generics pharmaceutical company with a  market share including  active pharmaceutical ingredients reddy’s has promoted india’s first integrated drug development company perlecan pharma pvt ltd together with icici ventures capital fund management company ltd and citigroup venture capital international growth partnership mauritius ltd the combined entity will undertake clinical development and outlicensing of new chemical entity assets dr reddys is presently licensed by merck  co to sell an authorized generic version of the popular drug simvastatin zocor in the usa since dr reddys has a license from merck it was not subject to the exclusivity period on generic simvastatin as of  dr reddy’s laboratories exceeded  million usd in revenues flowing from their apis branded formulations and generics segments the former two segments account for almost  of revenues dr reddys deals in and manages all the processes from the development of the api to the submission of finished dosage dossiers to the regulatory agencies patientcentric initiativesedit in september  dr reddy’s launched “purple health” in india a patient centric platform to deliver solutions that address unmet needs of patients purple health will address unmet needs of patients involving four segments awareness access access to medication adherence adherence to therapy and experience simplified medication experience the first step in this program will be the launch of new patient friendly packaging for its top  bestselling brands which will be rolledout in a phased manner over the next six months the packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy a tab at the bottom with expiry date clearly mentioned and a pictorial representation of the time the medicine needs to be taken in case of bottles the measuring cup is now easy to read and neck of the bottle has been modified to ensure minimal spillage purple health also includes patient support services for example someone taking medicines for an advanced kidney condition would be supported by messages and counselling on diet medicine and so on issues and recallsedit drug discovery problemsedit in september  dr reddys spun off its drug discovery and research wing into a separate company called perlecan pharma private limited at the time this was hailed as an innovative move but in  the company had to be wound down due to funding constraints dr reddys was the first indian pharma company to attempt such an effort to decouple risk of drug discovery from the parent company by creating a separate company with external source of funding perlecan pharma was partially funded by icici venture capital and citigroup venture international both of which held a  stake in perlecan for an estimated  million however the company was forced to buy back the perlecan shares from icici and citigroup due to doubts regarding the commercial viability of the drug candidates that were in perlecans pipeline at that point perlecan became a wholly owned subsidiary in the board meeting of  october  the company chose to amalgamateabsorb perlecan thereby making it an inhouse research facility as it was before  in  the company did a uturn and has handed over discovery research and related intellectual property to its bangalorebased subsidiary with the possibility of spinning it off as a different entity altogether the company may be hoping to find a strategic partner in the future to share the risks and research funding  recalledit in june  certain lots of dr reddys generic simvastatin tablets were recalled due to tablets having a musty or moldy smell on june   the new york times published an article warning unheeded heart drugs are recalled in which it said another large indian manufacturer and dr reddys laboratories have announced recalls over the past two months totalling more than  bottles of a widely used heart drug toprol xl because their products were not dissolving properly  fda form edit in december  the fda issues a form  letter over concerns discovered during an inspection of its srikakulam facility no specific violations were mentioned in the letter key peopleedit as of  march   board members and senior executives included mr satish reddy  chairman mr gv prasad  cochairman  ceo mr ravi bhoothalingam  independent director mr anupam puri  independent director dr omkar goswami  independent director dr jp moreau  independent director ms kalpana morparia  independent director dr bruce la carter  independent director dr ashok ganguly  independent director mr sridar iyengar  independent director key productsedit top active pharmaceutical ingredientsedit ciprofloxacin hydrochloride ramipril terbinafine hci ibuprofen sertaline hydrochloride ranitidine hci form  naproxen sodium naproxen atorvastatin montelukast losartan potassium sparfloxacin nizatidine fexofenadine ranitidine hydrochloride form  clopidogrel not in us due to  patent case omeprazole finasteride sumatriptan top brands by dr reddysedit this section does not cite any sources please help improve this section by adding citations to reliable sources unsourced material may be challenged and removed may  learn how and when to remove this template message north america india russia decitabine injection omez nise otc omeprazole mg omezdsr omez azacitidine nise ketorol metoprolol er stamlo cetrine zolendronic acid reclast reditux ciprolet fondaparinux fondared senade omeprazole dr razo sirdalud tacrolimus razod ibuclin atorvastatin atocor novigan otc fexo econorm femibion see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b drreddys laboratories ltd results   archived copy pdf archived from the original pdf on  may  retrieved    indias most trusted brands  archived from the original on  may    dr reddys laboratories  – marketreportscom  life sciences research report technology networks sudbury essex uk archived  january  at the wayback machineaccessed   dr reddys laboratories limited says not to sell any businessdj reuters news agency  march accessed  october   pfizer in talks to buy drl’s formulations business in india ndtv new delhi  february accessed  october   dr reddys develops generic version of pfizers lipitor business standard new delhi and mumbai  november accessed  october   pfizer sues dr reddy’s over cholesterol drug ‘lipitor’  stock watch mumbai  november accessed  october   astrazeneca partners with indias torrent pharmaceuticals pharmaceutical technology iselin nj and chester uk archived  july  at the wayback machineaccessed  october   dr reddys laboratories will no longer produce its medicines in russia – pravdaru  february accessed   httpinreuterscomarticleucbsadrreddysdealsidinkbnmshk  httpwwwlivemintcomcompaniesbcrfqvlenfoouydqawmdrreddysentersintoinlicensingpactwithusbasedxenophtml  dr reddy’s receives exclusive rights for zocor archived  february  at the wayback machine  httphealtheconomictimesindiatimescomnewspharmadrreddyslaunchespurplehealth  a b httptimesofindiaindiatimescombusinessindiabusinessdrreddyslaunchespatientfriendlypackagingoncertainmedicinesarticleshowcms  a b httpwwwthehindubusinesslinecomcompaniesdrlrollsoutpatientcentricpurplehealthinitiativearticleecerefwlnews  a b perlecan highlights rd travails of indian pharma   october accessed   drl moving research arm to bangalore unit  may  accessed   recall notice listserv california board of pharmacy  june   httpwwwfiercepharmamanufacturingcomstoryfdaslapsdrreddysform  httpwwwinpharmatechnologistcomingredientsdrreddysapiplantreceivesusfdawithnineobservations  httpwwwdrreddyscomourstoryleadershipboardofdirectors external linksedit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra  mahindra tafe tata motors tvs aerospace  defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti dcm essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw lt lanco mahindra muthoot murugappa rpsanjiv goenka group ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways spicejet goair consumer goods  retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages patanjali ayurved emami energy  natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci vedanta limited suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu  kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical  biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr reddys idpl iil lupin sun pharmaceutical manufacturing  heavy industries acc ambuja apollo tyres asian paints ltd bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mittal steel company mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media zee entertainment enterprises telecommunications aircel airtel bsnl idea cellular jio micromax mobile mtnl reliance communications tata communications benchmark fy  revenues of over us  billion v t e cnx nifty companies of india acc ambuja cements asian paints ltd axis bank bajaj auto bank of baroda bhel bpcl bharti airtel cairn india cipla coal india dlf dr reddys laboratories gail grasim industries hcl technologies hdfc hdfc bank hero motocorp hindalco industries hul infosys icici bank idfc indusind bank ltd itc limited jindal steel and power kotak mahindra bank lt lupin mahindra  mahindra maruti udyog nmdc ntpc ongc power grid corporation pnb reliance industries sesa sterlite limited sbi sun pharmaceutical tcs tata motors tata power tata steel tech mahindra ultratech cement wipro zee entertainment enterprises retrieved from httpsenwikipediaorgwindexphptitledrreddyslaboratoriesoldid categories companies listed on the new york stock exchangepharmaceutical companies of indiacompanies based in hyderabad indiacompanies listed on the bombay stock exchangemultinational companies headquartered in indiaindian companies established in cnx niftypharmaceutical companies established in indian brandshidden categories webarchive template wayback linksengvarb from january use dmy dates from january pages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from september articles needing additional references from may all articles needing additional references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages العربيةdeutschفارسیfrançaisहिन्दीಕನ್ನಡromânăрусскийதமிழ்తెలుగుtiếng việt edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view d srinivasa reddy  wikipedia d srinivasa reddy from wikipedia the free encyclopedia jump to navigation search d srinivasa reddy born  april   age  andhra pradesh india residence pune maharashtra india nationality indian fields organic chemistry medicinal chemistry institutions dr reddys laboratories advinus therapeutics national chemical laboratory alma mater osmania university university of hyderabad indian institute of science university of chicago university of kansas doctoral advisor goverdhan mehta sergey a kozmin jeffrey aubé known for siliconswitch approach notable awards  central drug research institute research excellence award  crsi bronze medal  nasireliance industries platinum jubilee award  shanti swarup bhatnagar prize dumbala srinivasa reddy born  is an indian organic and medicinal chemist and a senior scientist at national chemical laboratory he is known for the application of siliconswitch approach a management protocol for treating diseases affecting the central nervous system in his researches and is a recipient of the bronze medal of the chemical research society of india nasireliance industries platinum jubilee award and the drug research excellence award of the central drug research institute the council of scientific and industrial research the apex agency of the government of india for scientific research awarded him the shanti swarup bhatnagar prize for science and technology one of the highest indian science awards in  for his contributions to chemical sciences contents  biography  legacy  awards and honors  see also  references  external links biographyedit national chemical laboratory born on  april  in the south indian state of andhra pradesh d srinivasa reddy graduated in chemistry in  from osmania university and completed his masters degree from the same institution in  enrolling for his doctoral studies under the guidance of goverdhan mehta a noted chemist and former vice chancellor of university of hyderabad he moved to indian institute of science when mehta took up the position as the head of the department of organic chemistry at iisc his phd came from hyderabad university in  and he proceeded to the us where he did his postdoctoral work at the laboratories of sergey a kozmin of the university of chicago and jeffrey aubé of university of kansas during – he started his career in  as a principal scientist at dr reddy’s laboratories and became a research investigator in  but a year later he moved to advinus therapeutics as the group leader of their discovery chemistry research wing in  he was promoted as the section head soon after he left for national chemical laboratory where he works as a senior scientist legacyedit reddys researches have been focused on total organic synthesis of molecules with a view to their applications in agricultural and medicinal uses he is credited with the total synthesis of over  agrochemicals which includes a mealy bugattracting sex pheromone that has reported use in crop protection he has also developed several other products that has potential uses as celladhesion inhibitors antibacterial antiinflammatory as well as anticancer agents and as insect repellents he employs the siliconswitch approach for developing drug strategies for diseases affecting the central nervous system and his work has assisted in the drug discovery for the treatment of some infectious diseases as well as diabetes his researches have been documented by way of a number of peerreviewed articles google scholar an online article repository of scientific articles has listed  of them respectively he has also applied for  patents based on his researches awards and honorsedit dr d srinivasa reddy of ncl receives the shanti swarup bhatnagar prize  group picture new delhi india reddy received the award for excellence in drug research of the central drug research institute in  and the scientist of the year award of the national chemical laboratory the same year he received three awards in  starting with the nasireliance industries platinum jubilee award followed by the bronze medal of the chemical research society of india the council of scientific and industrial research awarded him the shanti swarup bhatnagar prize one of the highest indian science awards also in  see alsoedit goverdhan mehta india portal chemistry portal referencesedit  brief profile of the awardee shanti swarup bhatnagar prize  retrieved november     a b research details national chemical laboratory    a b c ncl’s d srinivasa reddy has been selected for this year’s nasireliance industries platinum jubilee award times of india june     cdri award pdf central drug research institute    view bhatnagar awardees shanti swarup bhatnagar prize  retrieved november     a b biography pdf national chemical laboratory    reddy on csir pdf council of scientific and industrial research    professional experience national chemical laboratory    a b dr srinivasa reddy of csirncl bags the prestigious shanti swarup bhatnagar prize biospectrum september     on researchgate researchgate    on google scholar google scholar    list of patents google patents    n vasudevan gorakhnath r jachak d srinivasa reddy december  breaking and making of rings european journal of organic chemistry  – doiejoc   b seetharamsingh remya ramesh santoshkumar s dange pankaj v khairnar smita singhal dilip upadhyay sridhar veeraraghavan srikant viswanadha swaroop vakkalanka d srinivasa reddy october  design synthesis and identification of silicon incorporated oxazolidinone antibiotics with improved brain exposure acs med chem lett doiacsmedchemlettb   awards and recognition national chemical laboratory    chemical sciences council of scientific and industrial research   external linksedit d srinivasa reddy scientist profile one organic chemist one day   d srinivasa reddy various links new drug approvals   d srinivasa reddy various links all for drugs   d srinivasa reddy product linkssilico linezolid silinezolid nds  organic spectroscopy international   d srinivasa reddy personal profile linkedin   d srinivasa reddy personal profile researchgate   d srinivasa reddy personal profile facebook   d srinivasa reddy patent highlight new drug approvals   d srinivasa reddy various links one organic chemist one day   v t e recipients of shanti swarup bhatnagar prize for science and technology in chemical science recipients tuticorin raghavachari govindachari  asima chatterjee  s c bhattacharyya  b d tilak  sukh dev  sadhan basu  r c mehrotra  nanduri atchuta ramaiah  mushi santappa  c n r rao  a c jain  p t narasimhan  m m dhar  s v kessar  a p b sinha  m v george  h b mathur  u r ghatak  k nagarajan  d s bhakuni  animesh chakravorty  devadas devaprabhakara  mihir chowdhury  s ranganathan  girjesh govil  goverdhan mehta  d balasubramanian  b m deb  c l khetrapal  g s r subba rao  samaresh mitra  naba kishore ray  paramasivam natarajan  k j rao  p balaram  debashis mukherjee  kaushal kishore  srinivasan chandrasekaran  m k chaudhuri  b m choudary  n sathyamurthy  biman bagchi  j s yadav  sumit bhaduri  suryanarayanasastry ramasesha  s r gadre  t ramasami  e d jemmis  d d sarma  jayaraman chandrasekhar  k l sebastian  narayanan chandrakumar  mariappan periasamy  kankan bhattacharyya  adusumilli srikrishna  a r chakravarty  k n ganesh  ganesh prasad pandey  deb shankar ray  sourav pal  pradeep mathur  uday maitra  t k chandrashekar  murali sastry  t k chakraborty  santanu bhattacharya  s ramakrishnan  srinivasan sampath  k george thomas  amalendu chandra  a ajayghosh  thalappil pradeep  jarugu narasimha moorthy  charusita chakravarty  narayanaswamy jayaraman swapan kumar pati  sandeep verma  balasubramanian sundaram  garikapati narahari sastry  gangadhar j sanjayan  govindasamy mugesh  yamuna krishnan  kavirayani ramakrishna prasad  souvik maiti  pradyut ghosh  d srinivasa reddy  partha sarathi mukherjee  all the branches biological science chemical science engineering science mathematical science medical science physical science earth atmosphere ocean  planetary sciences retrieved from httpsenwikipediaorgwindexphptitledsrinivasareddyoldid categories recipients of the shanti swarup bhatnagar award in chemical science birthsindian scientific authorsliving peoplescientists from andhra pradeshosmania university alumniindian institute of science alumniuniversity of chicago alumniuniversity of kansas alumnithcentury indian inventorsalumni of the university of hyderabad navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view d srinivasa reddy  wikipedia d srinivasa reddy from wikipedia the free encyclopedia jump to navigation search d srinivasa reddy born  april   age  andhra pradesh india residence pune maharashtra india nationality indian fields organic chemistry medicinal chemistry institutions dr reddys laboratories advinus therapeutics national chemical laboratory alma mater osmania university university of hyderabad indian institute of science university of chicago university of kansas doctoral advisor goverdhan mehta sergey a kozmin jeffrey aubé known for siliconswitch approach notable awards  central drug research institute research excellence award  crsi bronze medal  nasireliance industries platinum jubilee award  shanti swarup bhatnagar prize dumbala srinivasa reddy born  is an indian organic and medicinal chemist and a senior scientist at national chemical laboratory he is known for the application of siliconswitch approach a management protocol for treating diseases affecting the central nervous system in his researches and is a recipient of the bronze medal of the chemical research society of india nasireliance industries platinum jubilee award and the drug research excellence award of the central drug research institute the council of scientific and industrial research the apex agency of the government of india for scientific research awarded him the shanti swarup bhatnagar prize for science and technology one of the highest indian science awards in  for his contributions to chemical sciences contents  biography  legacy  awards and honors  see also  references  external links biographyedit national chemical laboratory born on  april  in the south indian state of andhra pradesh d srinivasa reddy graduated in chemistry in  from osmania university and completed his masters degree from the same institution in  enrolling for his doctoral studies under the guidance of goverdhan mehta a noted chemist and former vice chancellor of university of hyderabad he moved to indian institute of science when mehta took up the position as the head of the department of organic chemistry at iisc his phd came from hyderabad university in  and he proceeded to the us where he did his postdoctoral work at the laboratories of sergey a kozmin of the university of chicago and jeffrey aubé of university of kansas during – he started his career in  as a principal scientist at dr reddy’s laboratories and became a research investigator in  but a year later he moved to advinus therapeutics as the group leader of their discovery chemistry research wing in  he was promoted as the section head soon after he left for national chemical laboratory where he works as a senior scientist legacyedit reddys researches have been focused on total organic synthesis of molecules with a view to their applications in agricultural and medicinal uses he is credited with the total synthesis of over  agrochemicals which includes a mealy bugattracting sex pheromone that has reported use in crop protection he has also developed several other products that has potential uses as celladhesion inhibitors antibacterial antiinflammatory as well as anticancer agents and as insect repellents he employs the siliconswitch approach for developing drug strategies for diseases affecting the central nervous system and his work has assisted in the drug discovery for the treatment of some infectious diseases as well as diabetes his researches have been documented by way of a number of peerreviewed articles google scholar an online article repository of scientific articles has listed  of them respectively he has also applied for  patents based on his researches awards and honorsedit dr d srinivasa reddy of ncl receives the shanti swarup bhatnagar prize  group picture new delhi india reddy received the award for excellence in drug research of the central drug research institute in  and the scientist of the year award of the national chemical laboratory the same year he received three awards in  starting with the nasireliance industries platinum jubilee award followed by the bronze medal of the chemical research society of india the council of scientific and industrial research awarded him the shanti swarup bhatnagar prize one of the highest indian science awards also in  see alsoedit goverdhan mehta india portal chemistry portal referencesedit  brief profile of the awardee shanti swarup bhatnagar prize  retrieved november     a b research details national chemical laboratory    a b c ncl’s d srinivasa reddy has been selected for this year’s nasireliance industries platinum jubilee award times of india june     cdri award pdf central drug research institute    view bhatnagar awardees shanti swarup bhatnagar prize  retrieved november     a b biography pdf national chemical laboratory    reddy on csir pdf council of scientific and industrial research    professional experience national chemical laboratory    a b dr srinivasa reddy of csirncl bags the prestigious shanti swarup bhatnagar prize biospectrum september     on researchgate researchgate    on google scholar google scholar    list of patents google patents    n vasudevan gorakhnath r jachak d srinivasa reddy december  breaking and making of rings european journal of organic chemistry  – doiejoc   b seetharamsingh remya ramesh santoshkumar s dange pankaj v khairnar smita singhal dilip upadhyay sridhar veeraraghavan srikant viswanadha swaroop vakkalanka d srinivasa reddy october  design synthesis and identification of silicon incorporated oxazolidinone antibiotics with improved brain exposure acs med chem lett doiacsmedchemlettb   awards and recognition national chemical laboratory    chemical sciences council of scientific and industrial research   external linksedit d srinivasa reddy scientist profile one organic chemist one day   d srinivasa reddy various links new drug approvals   d srinivasa reddy various links all for drugs   d srinivasa reddy product linkssilico linezolid silinezolid nds  organic spectroscopy international   d srinivasa reddy personal profile linkedin   d srinivasa reddy personal profile researchgate   d srinivasa reddy personal profile facebook   d srinivasa reddy patent highlight new drug approvals   d srinivasa reddy various links one organic chemist one day   v t e recipients of shanti swarup bhatnagar prize for science and technology in chemical science recipients tuticorin raghavachari govindachari  asima chatterjee  s c bhattacharyya  b d tilak  sukh dev  sadhan basu  r c mehrotra  nanduri atchuta ramaiah  mushi santappa  c n r rao  a c jain  p t narasimhan  m m dhar  s v kessar  a p b sinha  m v george  h b mathur  u r ghatak  k nagarajan  d s bhakuni  animesh chakravorty  devadas devaprabhakara  mihir chowdhury  s ranganathan  girjesh govil  goverdhan mehta  d balasubramanian  b m deb  c l khetrapal  g s r subba rao  samaresh mitra  naba kishore ray  paramasivam natarajan  k j rao  p balaram  debashis mukherjee  kaushal kishore  srinivasan chandrasekaran  m k chaudhuri  b m choudary  n sathyamurthy  biman bagchi  j s yadav  sumit bhaduri  suryanarayanasastry ramasesha  s r gadre  t ramasami  e d jemmis  d d sarma  jayaraman chandrasekhar  k l sebastian  narayanan chandrakumar  mariappan periasamy  kankan bhattacharyya  adusumilli srikrishna  a r chakravarty  k n ganesh  ganesh prasad pandey  deb shankar ray  sourav pal  pradeep mathur  uday maitra  t k chandrashekar  murali sastry  t k chakraborty  santanu bhattacharya  s ramakrishnan  srinivasan sampath  k george thomas  amalendu chandra  a ajayghosh  thalappil pradeep  jarugu narasimha moorthy  charusita chakravarty  narayanaswamy jayaraman swapan kumar pati  sandeep verma  balasubramanian sundaram  garikapati narahari sastry  gangadhar j sanjayan  govindasamy mugesh  yamuna krishnan  kavirayani ramakrishna prasad  souvik maiti  pradyut ghosh  d srinivasa reddy  partha sarathi mukherjee  all the branches biological science chemical science engineering science mathematical science medical science physical science earth atmosphere ocean  planetary sciences retrieved from httpsenwikipediaorgwindexphptitledsrinivasareddyoldid categories recipients of the shanti swarup bhatnagar award in chemical science birthsindian scientific authorsliving peoplescientists from andhra pradeshosmania university alumniindian institute of science alumniuniversity of chicago alumniuniversity of kansas alumnithcentury indian inventorsalumni of the university of hyderabad navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view d srinivasa reddy  wikipedia d srinivasa reddy from wikipedia the free encyclopedia jump to navigation search d srinivasa reddy born  april   age  andhra pradesh india residence pune maharashtra india nationality indian fields organic chemistry medicinal chemistry institutions dr reddys laboratories advinus therapeutics national chemical laboratory alma mater osmania university university of hyderabad indian institute of science university of chicago university of kansas doctoral advisor goverdhan mehta sergey a kozmin jeffrey aubé known for siliconswitch approach notable awards  central drug research institute research excellence award  crsi bronze medal  nasireliance industries platinum jubilee award  shanti swarup bhatnagar prize dumbala srinivasa reddy born  is an indian organic and medicinal chemist and a senior scientist at national chemical laboratory he is known for the application of siliconswitch approach a management protocol for treating diseases affecting the central nervous system in his researches and is a recipient of the bronze medal of the chemical research society of india nasireliance industries platinum jubilee award and the drug research excellence award of the central drug research institute the council of scientific and industrial research the apex agency of the government of india for scientific research awarded him the shanti swarup bhatnagar prize for science and technology one of the highest indian science awards in  for his contributions to chemical sciences contents  biography  legacy  awards and honors  see also  references  external links biographyedit national chemical laboratory born on  april  in the south indian state of andhra pradesh d srinivasa reddy graduated in chemistry in  from osmania university and completed his masters degree from the same institution in  enrolling for his doctoral studies under the guidance of goverdhan mehta a noted chemist and former vice chancellor of university of hyderabad he moved to indian institute of science when mehta took up the position as the head of the department of organic chemistry at iisc his phd came from hyderabad university in  and he proceeded to the us where he did his postdoctoral work at the laboratories of sergey a kozmin of the university of chicago and jeffrey aubé of university of kansas during – he started his career in  as a principal scientist at dr reddy’s laboratories and became a research investigator in  but a year later he moved to advinus therapeutics as the group leader of their discovery chemistry research wing in  he was promoted as the section head soon after he left for national chemical laboratory where he works as a senior scientist legacyedit reddys researches have been focused on total organic synthesis of molecules with a view to their applications in agricultural and medicinal uses he is credited with the total synthesis of over  agrochemicals which includes a mealy bugattracting sex pheromone that has reported use in crop protection he has also developed several other products that has potential uses as celladhesion inhibitors antibacterial antiinflammatory as well as anticancer agents and as insect repellents he employs the siliconswitch approach for developing drug strategies for diseases affecting the central nervous system and his work has assisted in the drug discovery for the treatment of some infectious diseases as well as diabetes his researches have been documented by way of a number of peerreviewed articles google scholar an online article repository of scientific articles has listed  of them respectively he has also applied for  patents based on his researches awards and honorsedit dr d srinivasa reddy of ncl receives the shanti swarup bhatnagar prize  group picture new delhi india reddy received the award for excellence in drug research of the central drug research institute in  and the scientist of the year award of the national chemical laboratory the same year he received three awards in  starting with the nasireliance industries platinum jubilee award followed by the bronze medal of the chemical research society of india the council of scientific and industrial research awarded him the shanti swarup bhatnagar prize one of the highest indian science awards also in  see alsoedit goverdhan mehta india portal chemistry portal referencesedit  brief profile of the awardee shanti swarup bhatnagar prize  retrieved november     a b research details national chemical laboratory    a b c ncl’s d srinivasa reddy has been selected for this year’s nasireliance industries platinum jubilee award times of india june     cdri award pdf central drug research institute    view bhatnagar awardees shanti swarup bhatnagar prize  retrieved november     a b biography pdf national chemical laboratory    reddy on csir pdf council of scientific and industrial research    professional experience national chemical laboratory    a b dr srinivasa reddy of csirncl bags the prestigious shanti swarup bhatnagar prize biospectrum september     on researchgate researchgate    on google scholar google scholar    list of patents google patents    n vasudevan gorakhnath r jachak d srinivasa reddy december  breaking and making of rings european journal of organic chemistry  – doiejoc   b seetharamsingh remya ramesh santoshkumar s dange pankaj v khairnar smita singhal dilip upadhyay sridhar veeraraghavan srikant viswanadha swaroop vakkalanka d srinivasa reddy october  design synthesis and identification of silicon incorporated oxazolidinone antibiotics with improved brain exposure acs med chem lett doiacsmedchemlettb   awards and recognition national chemical laboratory    chemical sciences council of scientific and industrial research   external linksedit d srinivasa reddy scientist profile one organic chemist one day   d srinivasa reddy various links new drug approvals   d srinivasa reddy various links all for drugs   d srinivasa reddy product linkssilico linezolid silinezolid nds  organic spectroscopy international   d srinivasa reddy personal profile linkedin   d srinivasa reddy personal profile researchgate   d srinivasa reddy personal profile facebook   d srinivasa reddy patent highlight new drug approvals   d srinivasa reddy various links one organic chemist one day   v t e recipients of shanti swarup bhatnagar prize for science and technology in chemical science recipients tuticorin raghavachari govindachari  asima chatterjee  s c bhattacharyya  b d tilak  sukh dev  sadhan basu  r c mehrotra  nanduri atchuta ramaiah  mushi santappa  c n r rao  a c jain  p t narasimhan  m m dhar  s v kessar  a p b sinha  m v george  h b mathur  u r ghatak  k nagarajan  d s bhakuni  animesh chakravorty  devadas devaprabhakara  mihir chowdhury  s ranganathan  girjesh govil  goverdhan mehta  d balasubramanian  b m deb  c l khetrapal  g s r subba rao  samaresh mitra  naba kishore ray  paramasivam natarajan  k j rao  p balaram  debashis mukherjee  kaushal kishore  srinivasan chandrasekaran  m k chaudhuri  b m choudary  n sathyamurthy  biman bagchi  j s yadav  sumit bhaduri  suryanarayanasastry ramasesha  s r gadre  t ramasami  e d jemmis  d d sarma  jayaraman chandrasekhar  k l sebastian  narayanan chandrakumar  mariappan periasamy  kankan bhattacharyya  adusumilli srikrishna  a r chakravarty  k n ganesh  ganesh prasad pandey  deb shankar ray  sourav pal  pradeep mathur  uday maitra  t k chandrashekar  murali sastry  t k chakraborty  santanu bhattacharya  s ramakrishnan  srinivasan sampath  k george thomas  amalendu chandra  a ajayghosh  thalappil pradeep  jarugu narasimha moorthy  charusita chakravarty  narayanaswamy jayaraman swapan kumar pati  sandeep verma  balasubramanian sundaram  garikapati narahari sastry  gangadhar j sanjayan  govindasamy mugesh  yamuna krishnan  kavirayani ramakrishna prasad  souvik maiti  pradyut ghosh  d srinivasa reddy  partha sarathi mukherjee  all the branches biological science chemical science engineering science mathematical science medical science physical science earth atmosphere ocean  planetary sciences retrieved from httpsenwikipediaorgwindexphptitledsrinivasareddyoldid categories recipients of the shanti swarup bhatnagar award in chemical science birthsindian scientific authorsliving peoplescientists from andhra pradeshosmania university alumniindian institute of science alumniuniversity of chicago alumniuniversity of kansas alumnithcentury indian inventorsalumni of the university of hyderabad navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  april  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view dr reddys laboratories  wikipedia dr reddys laboratories from wikipedia the free encyclopedia jump to navigation search rdy redirects here for the radar system see radar doppler multitarget dr reddys laboratories type public traded as nse drreddy bse  nyse rdy industry pharmaceuticals founded  founders kallam anji reddy headquarters hyderabad telangana india key people g v prasad ceo kallam satish reddy chairman revenue ₹ crore us billion  net income ₹ crore us million  total assets ₹ crore us billion  total equity ₹ crore us million  number of employees  april  website wwwdrreddyscom dr reddys laboratories is an indian multinational pharmaceutical company based in hyderabad telangana india the company was founded by anji reddy who previously worked in the mentor institute indian drugs and pharmaceuticals limited of hyderabad india dr reddys manufactures and markets a wide range of pharmaceuticals in india and overseas the company has over  medications  active pharmaceutical ingredients apis for drug manufacture diagnostic kits critical care and biotechnology products dr reddys began as a supplier to indian drug manufacturers but it soon started exporting to other lessregulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the us food and drug administration fda by the early s the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in moredeveloped economies this allowed their movement into regulated markets such as the us and europe in  dr reddy laboratories was listed among  of indias most trusted brands according to the brand trust report  a study conducted by trust research advisory a brand analytics company by  dr reddys had six fda plants producing active pharmaceutical ingredients in india and seven fdainspected and iso  quality and iso  environmental management certified plants making patientready medications – five of them in india and two in the uk in  the familycontrolled dr reddys denied that it was in talks to sell its generics business in india to us pharmaceutical giant pfizer which had been suing the company for alleged patent infringement after dr reddys announced that it intended to produce a generic version of atorvastatin marketed by pfizer as lipitor an anticholesterol medication reddys was already linked to uk pharmaceuticals multinational glaxo smithkline contents  company history  international expansion  new drug discovery  expansion and acquisition  american ipo and expansion into europe  global expansion  patientcentric initiatives  issues and recalls  drug discovery problems   recall   fda form   key people  key products  top active pharmaceutical ingredients  top brands by dr reddys  see also  references  external links company historyedit dr reddys originally launched in  producing active pharmaceutical ingredients in  reddys started operations on branded formulations within a year reddys had launched norilet the companys first recognized brand in india soon dr reddys obtained another success with omez its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the indian market at that time within a year reddys became the first indian company to export the active ingredients for pharmaceuticals to europe in  reddys started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products international expansionedit the companys first international move took it to russia in  there dr reddys formed a joint venture with the countrys biggest pharmaceuticals producer biomed they pulled out in  amid accusations of scandal involving a significant material loss due to the activities of moscows branch of reddys labs with the help of biomeds chief executive reddys sold the joint venture to the kremlinfriendly sistema group in  reddys entered into a joint venture in the middle east and created two formulation units there and in russia reddys exported bulk drugs to these formulation units which then converted them into finished products in  reddys started targeting the us generic market by building state of art manufacturing facilitycitation needed new drug discoveryedit biopharma finished dosage unit iii in hyderabad biopharma finished dosage unit i in hyderabad reddys path into new drug discovery involved targeting speciality generics products in western markets to create a foundation for drug discovery development of speciality generics was an important step for the companys growing interest in the development of new chemical entities the elements involved in creating a speciality generic such as innovation in the laboratory developing the compound and sending the sales team to the market are also stages in the development of a new specialty drug starting with speciality generics allowed the company to gain experience with those steps before moving on to creating brandnew drugs reddys also invested heavily in establishing rd labs and is the only indian company to have significant rd being undertaken overseas dr reddys research foundation was established in  and in order to do research in the area of new drug discovery at first the foundations drug research strategy revolved around searching for analogues focus has since changed to innovative rd hiring new scientists especially indian students studying abroad on doctoral and postdoctoral courses in  the foundation set up an american laboratory in atlanta dedicated to discovery and design of novel therapeutics the laboratory is called reddy us therapeutics inc rusti and its main aim is the discovery of nextgeneration drugs using genomics and proteomics reddys research thrust focused on large niche areas in western markets – anticancer antidiabetes cardiovascular and antiinfection drugscitation needed reddys international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities reddys merged cheminor drug limited cdl with the primary aim of supplying active pharmaceutical ingredients to the technically demanding markets of north america and europe this merger also gave reddys an entry into the valueadded generics business in the regulated markets of apis apis in medicine expansion and acquisitionedit by  reddys made the transition from being an api and bulk drug supplier to regulated markets like the usa and the uk and a branded formulations supplier in unregulated markets like india and russia into producing generics by filing an abbreviated new drug application anda in the usa the same year reddys outlicensed a molecule for clinical trials to novo nordisk a danish pharmaceutical company it strengthened its indian manufacturing operations by acquiring american remedies ltd in  this acquisition made reddy’s the third largest pharmaceutical company in india after ranbaxy and glaxo i ltd with a full spectrum of pharmaceutical products which included bulk drugs intermediates finished dosages chemical synthesis diagnostics and biotechnologycitation needed reddy’s started exploiting para  filing as a strategy in bringing new drugs to the market at a faster pace in  it submitted a para  application for omeprazole the drug that had been the cornerstone of its success in india in december  reddy’s had undertaken its first commercial launch of a generic product in the usa and its first product with market exclusivity was launched there in august  the same year it also became the first nonjapanese pharmaceutical company from the asiapacific region to obtain a new york stock exchange listing groundbreaking achievements for the indian pharmaceutical industrycitation needed in  reddy’s became the first indian company to launch the generic drug fluoxetine a generic version of eli lilly and company’s prozac with day market exclusivity in the usa prozac had sales in excess of  billion per year in the late s barr laboratories of the us obtained exclusivity for all of the approved dosage forms  mg  mg except one  mg which was obtained by reddy’s lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection the case to allow generic sales was heard twice by the federal circuit court and reddy’s won both hearings reddy’s generated nearly  million in revenue during the initial sixmonth exclusivity period with such high returns at stake reddy’s was gambling on the success of the litigation failure to win the case could have cost them millions of dollars depending on the length of the trial the fluoxetine marketing success was followed by the american launch of reddys housebranded ibuprofen tablets in   and  mg strengths in january  direct marketing under the reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable us generic business it was the first step in building reddy’s fullyfledged distribution network in the us marketcitation needed in  dr reddys laboratories bought the established brands of belgian drugmaker ucb sa in south asia for  billion rupees  million dr reddys laboratories also signed a licensing pact with xenoport for their experimental treatment to treat plaque psoriasis as per the agreement dr reddy’s will be granted exclusive us rights to develop and commercialize xp for all indications for an upfront payment of  million american ipo and expansion into europeedit in  reddy’s completed its us initial public offering of  million secured by american depositary receipts at that time the company also became listed on the new york stock exchange funds raised from the initial public offering helped reddy’s move into international production and take over technologybased companies in  reddy’s started its european operations by acquiring two pharmaceutical firms in the united kingdom the acquisition of bms laboratories and its wholly owned subsidiary meridian uk allowed reddy’s to expand geographically into the european market in  reddy’s also invested  million usd in equity capital into bio sciences ltd auriegene discovery technologies a contract research company was established as a fully owned subsidiary of reddy’s in  auriegenes objective was to gain experience in drug discovery through contract research for other pharmaceutical companies reddy’s entered into a venture investment agreement with icici bank an established indian banking company under the terms of the agreement icici venture agreed to fund the development registration and legal costs related to the commercialization of andas on a predetermined basis upon commercialization of these products dr reddys pays icici venture royalty on net sales for a period of  years global expansionedit the company elected to expand globally and acquired other entities in march  dr reddy’s acquired bms laboratories beverley and its wholly owned subsidiary meridian healthcare for  million euros these companies deal in oral solids liquids and packaging with manufacturing facilities in london and beverley in the uk recently dr reddy’s entered into an rd and commercialization agreement with argenta discovery ltd a private drug development company based in the uk for the treatment of chronic obstructive pulmonary disease copd dr reddy’s entered into a year agreement with rheoscience as of denmark for the joint development and commercialization of balaglitazone drf a molecule for the treatment of type diabetes rheoscience holds this product’s marketing rights for the european union and china while the rights for the us and the rest of the world will be held by dr reddy’s dr reddy’s conducted clinical trials of its cardiovascular drug rus  in belfast northern ireland in  the trials were conducted to study the safety and the pharmacokinetic profiles of the drug which is intended for the treatment of atherosclerosis a major cause of cardiovascular disorders dr reddy’s entered into a marketing agreement with eurodrug laboratories a pharmaceutical company based in netherlands for improving its product portfolio for respiratory diseases it introduced a secondgeneration xanthine bronchodilator doxofylline which is used for the treatment of asthma and copd patients in  reddy’s acquired trigenesis therapeutics inc a usbased private dermatology company this acquisition gave reddy’s access to proprietary products and technologies in the dermatology sector dr reddy’s para  application strategy for generic business received a severe setback when reddy’s lost the patent challenge in the case of pfizer’s drug norvasc amlodipine maleate a drug indicated for the treatment of hypertension and angina the cost involved in patent litigation as well as the unexpected loss of the patent challenge affected reddy’s plans to start speciality business in the us generic markets in march  dr reddy’s acquired betapharm arzneimittel gmbh from i for  million euros this is one of the largestever foreign acquisitions by an indian pharmaceutical company betapharm is germany’s fourthlargest generics pharmaceutical company with a  market share including  active pharmaceutical ingredients reddy’s has promoted india’s first integrated drug development company perlecan pharma pvt ltd together with icici ventures capital fund management company ltd and citigroup venture capital international growth partnership mauritius ltd the combined entity will undertake clinical development and outlicensing of new chemical entity assets dr reddys is presently licensed by merck  co to sell an authorized generic version of the popular drug simvastatin zocor in the usa since dr reddys has a license from merck it was not subject to the exclusivity period on generic simvastatin as of  dr reddy’s laboratories exceeded  million usd in revenues flowing from their apis branded formulations and generics segments the former two segments account for almost  of revenues dr reddys deals in and manages all the processes from the development of the api to the submission of finished dosage dossiers to the regulatory agencies patientcentric initiativesedit in september  dr reddy’s launched “purple health” in india a patient centric platform to deliver solutions that address unmet needs of patients purple health will address unmet needs of patients involving four segments awareness access access to medication adherence adherence to therapy and experience simplified medication experience the first step in this program will be the launch of new patient friendly packaging for its top  bestselling brands which will be rolledout in a phased manner over the next six months the packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy a tab at the bottom with expiry date clearly mentioned and a pictorial representation of the time the medicine needs to be taken in case of bottles the measuring cup is now easy to read and neck of the bottle has been modified to ensure minimal spillage purple health also includes patient support services for example someone taking medicines for an advanced kidney condition would be supported by messages and counselling on diet medicine and so on issues and recallsedit drug discovery problemsedit in september  dr reddys spun off its drug discovery and research wing into a separate company called perlecan pharma private limited at the time this was hailed as an innovative move but in  the company had to be wound down due to funding constraints dr reddys was the first indian pharma company to attempt such an effort to decouple risk of drug discovery from the parent company by creating a separate company with external source of funding perlecan pharma was partially funded by icici venture capital and citigroup venture international both of which held a  stake in perlecan for an estimated  million however the company was forced to buy back the perlecan shares from icici and citigroup due to doubts regarding the commercial viability of the drug candidates that were in perlecans pipeline at that point perlecan became a wholly owned subsidiary in the board meeting of  october  the company chose to amalgamateabsorb perlecan thereby making it an inhouse research facility as it was before  in  the company did a uturn and has handed over discovery research and related intellectual property to its bangalorebased subsidiary with the possibility of spinning it off as a different entity altogether the company may be hoping to find a strategic partner in the future to share the risks and research funding  recalledit in june  certain lots of dr reddys generic simvastatin tablets were recalled due to tablets having a musty or moldy smell on june   the new york times published an article warning unheeded heart drugs are recalled in which it said another large indian manufacturer and dr reddys laboratories have announced recalls over the past two months totalling more than  bottles of a widely used heart drug toprol xl because their products were not dissolving properly  fda form edit in december  the fda issues a form  letter over concerns discovered during an inspection of its srikakulam facility no specific violations were mentioned in the letter key peopleedit as of  march   board members and senior executives included mr satish reddy  chairman mr gv prasad  cochairman  ceo mr ravi bhoothalingam  independent director mr anupam puri  independent director dr omkar goswami  independent director dr jp moreau  independent director ms kalpana morparia  independent director dr bruce la carter  independent director dr ashok ganguly  independent director mr sridar iyengar  independent director key productsedit top active pharmaceutical ingredientsedit ciprofloxacin hydrochloride ramipril terbinafine hci ibuprofen sertaline hydrochloride ranitidine hci form  naproxen sodium naproxen atorvastatin montelukast losartan potassium sparfloxacin nizatidine fexofenadine ranitidine hydrochloride form  clopidogrel not in us due to  patent case omeprazole finasteride sumatriptan top brands by dr reddysedit this section does not cite any sources please help improve this section by adding citations to reliable sources unsourced material may be challenged and removed may  learn how and when to remove this template message north america india russia decitabine injection omez nise otc omeprazole mg omezdsr omez azacitidine nise ketorol metoprolol er stamlo cetrine zolendronic acid reclast reditux ciprolet fondaparinux fondared senade omeprazole dr razo sirdalud tacrolimus razod ibuclin atorvastatin atocor novigan otc fexo econorm femibion see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b drreddys laboratories ltd results   archived copy pdf archived from the original pdf on  may  retrieved    indias most trusted brands  archived from the original on  may    dr reddys laboratories  – marketreportscom  life sciences research report technology networks sudbury essex uk archived  january  at the wayback machineaccessed   dr reddys laboratories limited says not to sell any businessdj reuters news agency  march accessed  october   pfizer in talks to buy drl’s formulations business in india ndtv new delhi  february accessed  october   dr reddys develops generic version of pfizers lipitor business standard new delhi and mumbai  november accessed  october   pfizer sues dr reddy’s over cholesterol drug ‘lipitor’  stock watch mumbai  november accessed  october   astrazeneca partners with indias torrent pharmaceuticals pharmaceutical technology iselin nj and chester uk archived  july  at the wayback machineaccessed  october   dr reddys laboratories will no longer produce its medicines in russia – pravdaru  february accessed   httpinreuterscomarticleucbsadrreddysdealsidinkbnmshk  httpwwwlivemintcomcompaniesbcrfqvlenfoouydqawmdrreddysentersintoinlicensingpactwithusbasedxenophtml  dr reddy’s receives exclusive rights for zocor archived  february  at the wayback machine  httphealtheconomictimesindiatimescomnewspharmadrreddyslaunchespurplehealth  a b httptimesofindiaindiatimescombusinessindiabusinessdrreddyslaunchespatientfriendlypackagingoncertainmedicinesarticleshowcms  a b httpwwwthehindubusinesslinecomcompaniesdrlrollsoutpatientcentricpurplehealthinitiativearticleecerefwlnews  a b perlecan highlights rd travails of indian pharma   october accessed   drl moving research arm to bangalore unit  may  accessed   recall notice listserv california board of pharmacy  june   httpwwwfiercepharmamanufacturingcomstoryfdaslapsdrreddysform  httpwwwinpharmatechnologistcomingredientsdrreddysapiplantreceivesusfdawithnineobservations  httpwwwdrreddyscomourstoryleadershipboardofdirectors external linksedit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra  mahindra tafe tata motors tvs aerospace  defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti dcm essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw lt lanco mahindra muthoot murugappa rpsanjiv goenka group ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways spicejet goair consumer goods  retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages patanjali ayurved emami energy  natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci vedanta limited suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu  kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical  biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr reddys idpl iil lupin sun pharmaceutical manufacturing  heavy industries acc ambuja apollo tyres asian paints ltd bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mittal steel company mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media zee entertainment enterprises telecommunications aircel airtel bsnl idea cellular jio micromax mobile mtnl reliance communications tata communications benchmark fy  revenues of over us  billion v t e cnx nifty companies of india acc ambuja cements asian paints ltd axis bank bajaj auto bank of baroda bhel bpcl bharti airtel cairn india cipla coal india dlf dr reddys laboratories gail grasim industries hcl technologies hdfc hdfc bank hero motocorp hindalco industries hul infosys icici bank idfc indusind bank ltd itc limited jindal steel and power kotak mahindra bank lt lupin mahindra  mahindra maruti udyog nmdc ntpc ongc power grid corporation pnb reliance industries sesa sterlite limited sbi sun pharmaceutical tcs tata motors tata power tata steel tech mahindra ultratech cement wipro zee entertainment enterprises retrieved from httpsenwikipediaorgwindexphptitledrreddyslaboratoriesoldid categories companies listed on the new york stock exchangepharmaceutical companies of indiacompanies based in hyderabad indiacompanies listed on the bombay stock exchangemultinational companies headquartered in indiaindian companies established in cnx niftypharmaceutical companies established in indian brandshidden categories webarchive template wayback linksengvarb from january use dmy dates from january pages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from september articles needing additional references from may all articles needing additional references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages العربيةdeutschفارسیfrançaisहिन्दीಕನ್ನಡromânăрусскийதமிழ்తెలుగుtiếng việt edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view dr reddys laboratories  wikipedia dr reddys laboratories from wikipedia the free encyclopedia jump to navigation search rdy redirects here for the radar system see radar doppler multitarget dr reddys laboratories type public traded as nse drreddy bse  nyse rdy industry pharmaceuticals founded  founders kallam anji reddy headquarters hyderabad telangana india key people g v prasad ceo kallam satish reddy chairman revenue ₹ crore us billion  net income ₹ crore us million  total assets ₹ crore us billion  total equity ₹ crore us million  number of employees  april  website wwwdrreddyscom dr reddys laboratories is an indian multinational pharmaceutical company based in hyderabad telangana india the company was founded by anji reddy who previously worked in the mentor institute indian drugs and pharmaceuticals limited of hyderabad india dr reddys manufactures and markets a wide range of pharmaceuticals in india and overseas the company has over  medications  active pharmaceutical ingredients apis for drug manufacture diagnostic kits critical care and biotechnology products dr reddys began as a supplier to indian drug manufacturers but it soon started exporting to other lessregulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the us food and drug administration fda by the early s the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in moredeveloped economies this allowed their movement into regulated markets such as the us and europe in  dr reddy laboratories was listed among  of indias most trusted brands according to the brand trust report  a study conducted by trust research advisory a brand analytics company by  dr reddys had six fda plants producing active pharmaceutical ingredients in india and seven fdainspected and iso  quality and iso  environmental management certified plants making patientready medications – five of them in india and two in the uk in  the familycontrolled dr reddys denied that it was in talks to sell its generics business in india to us pharmaceutical giant pfizer which had been suing the company for alleged patent infringement after dr reddys announced that it intended to produce a generic version of atorvastatin marketed by pfizer as lipitor an anticholesterol medication reddys was already linked to uk pharmaceuticals multinational glaxo smithkline contents  company history  international expansion  new drug discovery  expansion and acquisition  american ipo and expansion into europe  global expansion  patientcentric initiatives  issues and recalls  drug discovery problems   recall   fda form   key people  key products  top active pharmaceutical ingredients  top brands by dr reddys  see also  references  external links company historyedit dr reddys originally launched in  producing active pharmaceutical ingredients in  reddys started operations on branded formulations within a year reddys had launched norilet the companys first recognized brand in india soon dr reddys obtained another success with omez its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the indian market at that time within a year reddys became the first indian company to export the active ingredients for pharmaceuticals to europe in  reddys started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products international expansionedit the companys first international move took it to russia in  there dr reddys formed a joint venture with the countrys biggest pharmaceuticals producer biomed they pulled out in  amid accusations of scandal involving a significant material loss due to the activities of moscows branch of reddys labs with the help of biomeds chief executive reddys sold the joint venture to the kremlinfriendly sistema group in  reddys entered into a joint venture in the middle east and created two formulation units there and in russia reddys exported bulk drugs to these formulation units which then converted them into finished products in  reddys started targeting the us generic market by building state of art manufacturing facilitycitation needed new drug discoveryedit biopharma finished dosage unit iii in hyderabad biopharma finished dosage unit i in hyderabad reddys path into new drug discovery involved targeting speciality generics products in western markets to create a foundation for drug discovery development of speciality generics was an important step for the companys growing interest in the development of new chemical entities the elements involved in creating a speciality generic such as innovation in the laboratory developing the compound and sending the sales team to the market are also stages in the development of a new specialty drug starting with speciality generics allowed the company to gain experience with those steps before moving on to creating brandnew drugs reddys also invested heavily in establishing rd labs and is the only indian company to have significant rd being undertaken overseas dr reddys research foundation was established in  and in order to do research in the area of new drug discovery at first the foundations drug research strategy revolved around searching for analogues focus has since changed to innovative rd hiring new scientists especially indian students studying abroad on doctoral and postdoctoral courses in  the foundation set up an american laboratory in atlanta dedicated to discovery and design of novel therapeutics the laboratory is called reddy us therapeutics inc rusti and its main aim is the discovery of nextgeneration drugs using genomics and proteomics reddys research thrust focused on large niche areas in western markets – anticancer antidiabetes cardiovascular and antiinfection drugscitation needed reddys international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities reddys merged cheminor drug limited cdl with the primary aim of supplying active pharmaceutical ingredients to the technically demanding markets of north america and europe this merger also gave reddys an entry into the valueadded generics business in the regulated markets of apis apis in medicine expansion and acquisitionedit by  reddys made the transition from being an api and bulk drug supplier to regulated markets like the usa and the uk and a branded formulations supplier in unregulated markets like india and russia into producing generics by filing an abbreviated new drug application anda in the usa the same year reddys outlicensed a molecule for clinical trials to novo nordisk a danish pharmaceutical company it strengthened its indian manufacturing operations by acquiring american remedies ltd in  this acquisition made reddy’s the third largest pharmaceutical company in india after ranbaxy and glaxo i ltd with a full spectrum of pharmaceutical products which included bulk drugs intermediates finished dosages chemical synthesis diagnostics and biotechnologycitation needed reddy’s started exploiting para  filing as a strategy in bringing new drugs to the market at a faster pace in  it submitted a para  application for omeprazole the drug that had been the cornerstone of its success in india in december  reddy’s had undertaken its first commercial launch of a generic product in the usa and its first product with market exclusivity was launched there in august  the same year it also became the first nonjapanese pharmaceutical company from the asiapacific region to obtain a new york stock exchange listing groundbreaking achievements for the indian pharmaceutical industrycitation needed in  reddy’s became the first indian company to launch the generic drug fluoxetine a generic version of eli lilly and company’s prozac with day market exclusivity in the usa prozac had sales in excess of  billion per year in the late s barr laboratories of the us obtained exclusivity for all of the approved dosage forms  mg  mg except one  mg which was obtained by reddy’s lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection the case to allow generic sales was heard twice by the federal circuit court and reddy’s won both hearings reddy’s generated nearly  million in revenue during the initial sixmonth exclusivity period with such high returns at stake reddy’s was gambling on the success of the litigation failure to win the case could have cost them millions of dollars depending on the length of the trial the fluoxetine marketing success was followed by the american launch of reddys housebranded ibuprofen tablets in   and  mg strengths in january  direct marketing under the reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable us generic business it was the first step in building reddy’s fullyfledged distribution network in the us marketcitation needed in  dr reddys laboratories bought the established brands of belgian drugmaker ucb sa in south asia for  billion rupees  million dr reddys laboratories also signed a licensing pact with xenoport for their experimental treatment to treat plaque psoriasis as per the agreement dr reddy’s will be granted exclusive us rights to develop and commercialize xp for all indications for an upfront payment of  million american ipo and expansion into europeedit in  reddy’s completed its us initial public offering of  million secured by american depositary receipts at that time the company also became listed on the new york stock exchange funds raised from the initial public offering helped reddy’s move into international production and take over technologybased companies in  reddy’s started its european operations by acquiring two pharmaceutical firms in the united kingdom the acquisition of bms laboratories and its wholly owned subsidiary meridian uk allowed reddy’s to expand geographically into the european market in  reddy’s also invested  million usd in equity capital into bio sciences ltd auriegene discovery technologies a contract research company was established as a fully owned subsidiary of reddy’s in  auriegenes objective was to gain experience in drug discovery through contract research for other pharmaceutical companies reddy’s entered into a venture investment agreement with icici bank an established indian banking company under the terms of the agreement icici venture agreed to fund the development registration and legal costs related to the commercialization of andas on a predetermined basis upon commercialization of these products dr reddys pays icici venture royalty on net sales for a period of  years global expansionedit the company elected to expand globally and acquired other entities in march  dr reddy’s acquired bms laboratories beverley and its wholly owned subsidiary meridian healthcare for  million euros these companies deal in oral solids liquids and packaging with manufacturing facilities in london and beverley in the uk recently dr reddy’s entered into an rd and commercialization agreement with argenta discovery ltd a private drug development company based in the uk for the treatment of chronic obstructive pulmonary disease copd dr reddy’s entered into a year agreement with rheoscience as of denmark for the joint development and commercialization of balaglitazone drf a molecule for the treatment of type diabetes rheoscience holds this product’s marketing rights for the european union and china while the rights for the us and the rest of the world will be held by dr reddy’s dr reddy’s conducted clinical trials of its cardiovascular drug rus  in belfast northern ireland in  the trials were conducted to study the safety and the pharmacokinetic profiles of the drug which is intended for the treatment of atherosclerosis a major cause of cardiovascular disorders dr reddy’s entered into a marketing agreement with eurodrug laboratories a pharmaceutical company based in netherlands for improving its product portfolio for respiratory diseases it introduced a secondgeneration xanthine bronchodilator doxofylline which is used for the treatment of asthma and copd patients in  reddy’s acquired trigenesis therapeutics inc a usbased private dermatology company this acquisition gave reddy’s access to proprietary products and technologies in the dermatology sector dr reddy’s para  application strategy for generic business received a severe setback when reddy’s lost the patent challenge in the case of pfizer’s drug norvasc amlodipine maleate a drug indicated for the treatment of hypertension and angina the cost involved in patent litigation as well as the unexpected loss of the patent challenge affected reddy’s plans to start speciality business in the us generic markets in march  dr reddy’s acquired betapharm arzneimittel gmbh from i for  million euros this is one of the largestever foreign acquisitions by an indian pharmaceutical company betapharm is germany’s fourthlargest generics pharmaceutical company with a  market share including  active pharmaceutical ingredients reddy’s has promoted india’s first integrated drug development company perlecan pharma pvt ltd together with icici ventures capital fund management company ltd and citigroup venture capital international growth partnership mauritius ltd the combined entity will undertake clinical development and outlicensing of new chemical entity assets dr reddys is presently licensed by merck  co to sell an authorized generic version of the popular drug simvastatin zocor in the usa since dr reddys has a license from merck it was not subject to the exclusivity period on generic simvastatin as of  dr reddy’s laboratories exceeded  million usd in revenues flowing from their apis branded formulations and generics segments the former two segments account for almost  of revenues dr reddys deals in and manages all the processes from the development of the api to the submission of finished dosage dossiers to the regulatory agencies patientcentric initiativesedit in september  dr reddy’s launched “purple health” in india a patient centric platform to deliver solutions that address unmet needs of patients purple health will address unmet needs of patients involving four segments awareness access access to medication adherence adherence to therapy and experience simplified medication experience the first step in this program will be the launch of new patient friendly packaging for its top  bestselling brands which will be rolledout in a phased manner over the next six months the packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy a tab at the bottom with expiry date clearly mentioned and a pictorial representation of the time the medicine needs to be taken in case of bottles the measuring cup is now easy to read and neck of the bottle has been modified to ensure minimal spillage purple health also includes patient support services for example someone taking medicines for an advanced kidney condition would be supported by messages and counselling on diet medicine and so on issues and recallsedit drug discovery problemsedit in september  dr reddys spun off its drug discovery and research wing into a separate company called perlecan pharma private limited at the time this was hailed as an innovative move but in  the company had to be wound down due to funding constraints dr reddys was the first indian pharma company to attempt such an effort to decouple risk of drug discovery from the parent company by creating a separate company with external source of funding perlecan pharma was partially funded by icici venture capital and citigroup venture international both of which held a  stake in perlecan for an estimated  million however the company was forced to buy back the perlecan shares from icici and citigroup due to doubts regarding the commercial viability of the drug candidates that were in perlecans pipeline at that point perlecan became a wholly owned subsidiary in the board meeting of  october  the company chose to amalgamateabsorb perlecan thereby making it an inhouse research facility as it was before  in  the company did a uturn and has handed over discovery research and related intellectual property to its bangalorebased subsidiary with the possibility of spinning it off as a different entity altogether the company may be hoping to find a strategic partner in the future to share the risks and research funding  recalledit in june  certain lots of dr reddys generic simvastatin tablets were recalled due to tablets having a musty or moldy smell on june   the new york times published an article warning unheeded heart drugs are recalled in which it said another large indian manufacturer and dr reddys laboratories have announced recalls over the past two months totalling more than  bottles of a widely used heart drug toprol xl because their products were not dissolving properly  fda form edit in december  the fda issues a form  letter over concerns discovered during an inspection of its srikakulam facility no specific violations were mentioned in the letter key peopleedit as of  march   board members and senior executives included mr satish reddy  chairman mr gv prasad  cochairman  ceo mr ravi bhoothalingam  independent director mr anupam puri  independent director dr omkar goswami  independent director dr jp moreau  independent director ms kalpana morparia  independent director dr bruce la carter  independent director dr ashok ganguly  independent director mr sridar iyengar  independent director key productsedit top active pharmaceutical ingredientsedit ciprofloxacin hydrochloride ramipril terbinafine hci ibuprofen sertaline hydrochloride ranitidine hci form  naproxen sodium naproxen atorvastatin montelukast losartan potassium sparfloxacin nizatidine fexofenadine ranitidine hydrochloride form  clopidogrel not in us due to  patent case omeprazole finasteride sumatriptan top brands by dr reddysedit this section does not cite any sources please help improve this section by adding citations to reliable sources unsourced material may be challenged and removed may  learn how and when to remove this template message north america india russia decitabine injection omez nise otc omeprazole mg omezdsr omez azacitidine nise ketorol metoprolol er stamlo cetrine zolendronic acid reclast reditux ciprolet fondaparinux fondared senade omeprazole dr razo sirdalud tacrolimus razod ibuclin atorvastatin atocor novigan otc fexo econorm femibion see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b drreddys laboratories ltd results   archived copy pdf archived from the original pdf on  may  retrieved    indias most trusted brands  archived from the original on  may    dr reddys laboratories  – marketreportscom  life sciences research report technology networks sudbury essex uk archived  january  at the wayback machineaccessed   dr reddys laboratories limited says not to sell any businessdj reuters news agency  march accessed  october   pfizer in talks to buy drl’s formulations business in india ndtv new delhi  february accessed  october   dr reddys develops generic version of pfizers lipitor business standard new delhi and mumbai  november accessed  october   pfizer sues dr reddy’s over cholesterol drug ‘lipitor’  stock watch mumbai  november accessed  october   astrazeneca partners with indias torrent pharmaceuticals pharmaceutical technology iselin nj and chester uk archived  july  at the wayback machineaccessed  october   dr reddys laboratories will no longer produce its medicines in russia – pravdaru  february accessed   httpinreuterscomarticleucbsadrreddysdealsidinkbnmshk  httpwwwlivemintcomcompaniesbcrfqvlenfoouydqawmdrreddysentersintoinlicensingpactwithusbasedxenophtml  dr reddy’s receives exclusive rights for zocor archived  february  at the wayback machine  httphealtheconomictimesindiatimescomnewspharmadrreddyslaunchespurplehealth  a b httptimesofindiaindiatimescombusinessindiabusinessdrreddyslaunchespatientfriendlypackagingoncertainmedicinesarticleshowcms  a b httpwwwthehindubusinesslinecomcompaniesdrlrollsoutpatientcentricpurplehealthinitiativearticleecerefwlnews  a b perlecan highlights rd travails of indian pharma   october accessed   drl moving research arm to bangalore unit  may  accessed   recall notice listserv california board of pharmacy  june   httpwwwfiercepharmamanufacturingcomstoryfdaslapsdrreddysform  httpwwwinpharmatechnologistcomingredientsdrreddysapiplantreceivesusfdawithnineobservations  httpwwwdrreddyscomourstoryleadershipboardofdirectors external linksedit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra  mahindra tafe tata motors tvs aerospace  defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti dcm essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw lt lanco mahindra muthoot murugappa rpsanjiv goenka group ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways spicejet goair consumer goods  retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages patanjali ayurved emami energy  natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci vedanta limited suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu  kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical  biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr reddys idpl iil lupin sun pharmaceutical manufacturing  heavy industries acc ambuja apollo tyres asian paints ltd bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mittal steel company mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media zee entertainment enterprises telecommunications aircel airtel bsnl idea cellular jio micromax mobile mtnl reliance communications tata communications benchmark fy  revenues of over us  billion v t e cnx nifty companies of india acc ambuja cements asian paints ltd axis bank bajaj auto bank of baroda bhel bpcl bharti airtel cairn india cipla coal india dlf dr reddys laboratories gail grasim industries hcl technologies hdfc hdfc bank hero motocorp hindalco industries hul infosys icici bank idfc indusind bank ltd itc limited jindal steel and power kotak mahindra bank lt lupin mahindra  mahindra maruti udyog nmdc ntpc ongc power grid corporation pnb reliance industries sesa sterlite limited sbi sun pharmaceutical tcs tata motors tata power tata steel tech mahindra ultratech cement wipro zee entertainment enterprises retrieved from httpsenwikipediaorgwindexphptitledrreddyslaboratoriesoldid categories companies listed on the new york stock exchangepharmaceutical companies of indiacompanies based in hyderabad indiacompanies listed on the bombay stock exchangemultinational companies headquartered in indiaindian companies established in cnx niftypharmaceutical companies established in indian brandshidden categories webarchive template wayback linksengvarb from january use dmy dates from january pages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from september articles needing additional references from may all articles needing additional references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages العربيةdeutschفارسیfrançaisहिन्दीಕನ್ನಡromânăрусскийதமிழ்తెలుగుtiếng việt edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view dr reddys laboratories  wikipedia dr reddys laboratories from wikipedia the free encyclopedia jump to navigation search rdy redirects here for the radar system see radar doppler multitarget dr reddys laboratories type public traded as nse drreddy bse  nyse rdy industry pharmaceuticals founded  founders kallam anji reddy headquarters hyderabad telangana india key people g v prasad ceo kallam satish reddy chairman revenue ₹ crore us billion  net income ₹ crore us million  total assets ₹ crore us billion  total equity ₹ crore us million  number of employees  april  website wwwdrreddyscom dr reddys laboratories is an indian multinational pharmaceutical company based in hyderabad telangana india the company was founded by anji reddy who previously worked in the mentor institute indian drugs and pharmaceuticals limited of hyderabad india dr reddys manufactures and markets a wide range of pharmaceuticals in india and overseas the company has over  medications  active pharmaceutical ingredients apis for drug manufacture diagnostic kits critical care and biotechnology products dr reddys began as a supplier to indian drug manufacturers but it soon started exporting to other lessregulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the us food and drug administration fda by the early s the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in moredeveloped economies this allowed their movement into regulated markets such as the us and europe in  dr reddy laboratories was listed among  of indias most trusted brands according to the brand trust report  a study conducted by trust research advisory a brand analytics company by  dr reddys had six fda plants producing active pharmaceutical ingredients in india and seven fdainspected and iso  quality and iso  environmental management certified plants making patientready medications – five of them in india and two in the uk in  the familycontrolled dr reddys denied that it was in talks to sell its generics business in india to us pharmaceutical giant pfizer which had been suing the company for alleged patent infringement after dr reddys announced that it intended to produce a generic version of atorvastatin marketed by pfizer as lipitor an anticholesterol medication reddys was already linked to uk pharmaceuticals multinational glaxo smithkline contents  company history  international expansion  new drug discovery  expansion and acquisition  american ipo and expansion into europe  global expansion  patientcentric initiatives  issues and recalls  drug discovery problems   recall   fda form   key people  key products  top active pharmaceutical ingredients  top brands by dr reddys  see also  references  external links company historyedit dr reddys originally launched in  producing active pharmaceutical ingredients in  reddys started operations on branded formulations within a year reddys had launched norilet the companys first recognized brand in india soon dr reddys obtained another success with omez its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the indian market at that time within a year reddys became the first indian company to export the active ingredients for pharmaceuticals to europe in  reddys started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products international expansionedit the companys first international move took it to russia in  there dr reddys formed a joint venture with the countrys biggest pharmaceuticals producer biomed they pulled out in  amid accusations of scandal involving a significant material loss due to the activities of moscows branch of reddys labs with the help of biomeds chief executive reddys sold the joint venture to the kremlinfriendly sistema group in  reddys entered into a joint venture in the middle east and created two formulation units there and in russia reddys exported bulk drugs to these formulation units which then converted them into finished products in  reddys started targeting the us generic market by building state of art manufacturing facilitycitation needed new drug discoveryedit biopharma finished dosage unit iii in hyderabad biopharma finished dosage unit i in hyderabad reddys path into new drug discovery involved targeting speciality generics products in western markets to create a foundation for drug discovery development of speciality generics was an important step for the companys growing interest in the development of new chemical entities the elements involved in creating a speciality generic such as innovation in the laboratory developing the compound and sending the sales team to the market are also stages in the development of a new specialty drug starting with speciality generics allowed the company to gain experience with those steps before moving on to creating brandnew drugs reddys also invested heavily in establishing rd labs and is the only indian company to have significant rd being undertaken overseas dr reddys research foundation was established in  and in order to do research in the area of new drug discovery at first the foundations drug research strategy revolved around searching for analogues focus has since changed to innovative rd hiring new scientists especially indian students studying abroad on doctoral and postdoctoral courses in  the foundation set up an american laboratory in atlanta dedicated to discovery and design of novel therapeutics the laboratory is called reddy us therapeutics inc rusti and its main aim is the discovery of nextgeneration drugs using genomics and proteomics reddys research thrust focused on large niche areas in western markets – anticancer antidiabetes cardiovascular and antiinfection drugscitation needed reddys international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities reddys merged cheminor drug limited cdl with the primary aim of supplying active pharmaceutical ingredients to the technically demanding markets of north america and europe this merger also gave reddys an entry into the valueadded generics business in the regulated markets of apis apis in medicine expansion and acquisitionedit by  reddys made the transition from being an api and bulk drug supplier to regulated markets like the usa and the uk and a branded formulations supplier in unregulated markets like india and russia into producing generics by filing an abbreviated new drug application anda in the usa the same year reddys outlicensed a molecule for clinical trials to novo nordisk a danish pharmaceutical company it strengthened its indian manufacturing operations by acquiring american remedies ltd in  this acquisition made reddy’s the third largest pharmaceutical company in india after ranbaxy and glaxo i ltd with a full spectrum of pharmaceutical products which included bulk drugs intermediates finished dosages chemical synthesis diagnostics and biotechnologycitation needed reddy’s started exploiting para  filing as a strategy in bringing new drugs to the market at a faster pace in  it submitted a para  application for omeprazole the drug that had been the cornerstone of its success in india in december  reddy’s had undertaken its first commercial launch of a generic product in the usa and its first product with market exclusivity was launched there in august  the same year it also became the first nonjapanese pharmaceutical company from the asiapacific region to obtain a new york stock exchange listing groundbreaking achievements for the indian pharmaceutical industrycitation needed in  reddy’s became the first indian company to launch the generic drug fluoxetine a generic version of eli lilly and company’s prozac with day market exclusivity in the usa prozac had sales in excess of  billion per year in the late s barr laboratories of the us obtained exclusivity for all of the approved dosage forms  mg  mg except one  mg which was obtained by reddy’s lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection the case to allow generic sales was heard twice by the federal circuit court and reddy’s won both hearings reddy’s generated nearly  million in revenue during the initial sixmonth exclusivity period with such high returns at stake reddy’s was gambling on the success of the litigation failure to win the case could have cost them millions of dollars depending on the length of the trial the fluoxetine marketing success was followed by the american launch of reddys housebranded ibuprofen tablets in   and  mg strengths in january  direct marketing under the reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable us generic business it was the first step in building reddy’s fullyfledged distribution network in the us marketcitation needed in  dr reddys laboratories bought the established brands of belgian drugmaker ucb sa in south asia for  billion rupees  million dr reddys laboratories also signed a licensing pact with xenoport for their experimental treatment to treat plaque psoriasis as per the agreement dr reddy’s will be granted exclusive us rights to develop and commercialize xp for all indications for an upfront payment of  million american ipo and expansion into europeedit in  reddy’s completed its us initial public offering of  million secured by american depositary receipts at that time the company also became listed on the new york stock exchange funds raised from the initial public offering helped reddy’s move into international production and take over technologybased companies in  reddy’s started its european operations by acquiring two pharmaceutical firms in the united kingdom the acquisition of bms laboratories and its wholly owned subsidiary meridian uk allowed reddy’s to expand geographically into the european market in  reddy’s also invested  million usd in equity capital into bio sciences ltd auriegene discovery technologies a contract research company was established as a fully owned subsidiary of reddy’s in  auriegenes objective was to gain experience in drug discovery through contract research for other pharmaceutical companies reddy’s entered into a venture investment agreement with icici bank an established indian banking company under the terms of the agreement icici venture agreed to fund the development registration and legal costs related to the commercialization of andas on a predetermined basis upon commercialization of these products dr reddys pays icici venture royalty on net sales for a period of  years global expansionedit the company elected to expand globally and acquired other entities in march  dr reddy’s acquired bms laboratories beverley and its wholly owned subsidiary meridian healthcare for  million euros these companies deal in oral solids liquids and packaging with manufacturing facilities in london and beverley in the uk recently dr reddy’s entered into an rd and commercialization agreement with argenta discovery ltd a private drug development company based in the uk for the treatment of chronic obstructive pulmonary disease copd dr reddy’s entered into a year agreement with rheoscience as of denmark for the joint development and commercialization of balaglitazone drf a molecule for the treatment of type diabetes rheoscience holds this product’s marketing rights for the european union and china while the rights for the us and the rest of the world will be held by dr reddy’s dr reddy’s conducted clinical trials of its cardiovascular drug rus  in belfast northern ireland in  the trials were conducted to study the safety and the pharmacokinetic profiles of the drug which is intended for the treatment of atherosclerosis a major cause of cardiovascular disorders dr reddy’s entered into a marketing agreement with eurodrug laboratories a pharmaceutical company based in netherlands for improving its product portfolio for respiratory diseases it introduced a secondgeneration xanthine bronchodilator doxofylline which is used for the treatment of asthma and copd patients in  reddy’s acquired trigenesis therapeutics inc a usbased private dermatology company this acquisition gave reddy’s access to proprietary products and technologies in the dermatology sector dr reddy’s para  application strategy for generic business received a severe setback when reddy’s lost the patent challenge in the case of pfizer’s drug norvasc amlodipine maleate a drug indicated for the treatment of hypertension and angina the cost involved in patent litigation as well as the unexpected loss of the patent challenge affected reddy’s plans to start speciality business in the us generic markets in march  dr reddy’s acquired betapharm arzneimittel gmbh from i for  million euros this is one of the largestever foreign acquisitions by an indian pharmaceutical company betapharm is germany’s fourthlargest generics pharmaceutical company with a  market share including  active pharmaceutical ingredients reddy’s has promoted india’s first integrated drug development company perlecan pharma pvt ltd together with icici ventures capital fund management company ltd and citigroup venture capital international growth partnership mauritius ltd the combined entity will undertake clinical development and outlicensing of new chemical entity assets dr reddys is presently licensed by merck  co to sell an authorized generic version of the popular drug simvastatin zocor in the usa since dr reddys has a license from merck it was not subject to the exclusivity period on generic simvastatin as of  dr reddy’s laboratories exceeded  million usd in revenues flowing from their apis branded formulations and generics segments the former two segments account for almost  of revenues dr reddys deals in and manages all the processes from the development of the api to the submission of finished dosage dossiers to the regulatory agencies patientcentric initiativesedit in september  dr reddy’s launched “purple health” in india a patient centric platform to deliver solutions that address unmet needs of patients purple health will address unmet needs of patients involving four segments awareness access access to medication adherence adherence to therapy and experience simplified medication experience the first step in this program will be the launch of new patient friendly packaging for its top  bestselling brands which will be rolledout in a phased manner over the next six months the packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy a tab at the bottom with expiry date clearly mentioned and a pictorial representation of the time the medicine needs to be taken in case of bottles the measuring cup is now easy to read and neck of the bottle has been modified to ensure minimal spillage purple health also includes patient support services for example someone taking medicines for an advanced kidney condition would be supported by messages and counselling on diet medicine and so on issues and recallsedit drug discovery problemsedit in september  dr reddys spun off its drug discovery and research wing into a separate company called perlecan pharma private limited at the time this was hailed as an innovative move but in  the company had to be wound down due to funding constraints dr reddys was the first indian pharma company to attempt such an effort to decouple risk of drug discovery from the parent company by creating a separate company with external source of funding perlecan pharma was partially funded by icici venture capital and citigroup venture international both of which held a  stake in perlecan for an estimated  million however the company was forced to buy back the perlecan shares from icici and citigroup due to doubts regarding the commercial viability of the drug candidates that were in perlecans pipeline at that point perlecan became a wholly owned subsidiary in the board meeting of  october  the company chose to amalgamateabsorb perlecan thereby making it an inhouse research facility as it was before  in  the company did a uturn and has handed over discovery research and related intellectual property to its bangalorebased subsidiary with the possibility of spinning it off as a different entity altogether the company may be hoping to find a strategic partner in the future to share the risks and research funding  recalledit in june  certain lots of dr reddys generic simvastatin tablets were recalled due to tablets having a musty or moldy smell on june   the new york times published an article warning unheeded heart drugs are recalled in which it said another large indian manufacturer and dr reddys laboratories have announced recalls over the past two months totalling more than  bottles of a widely used heart drug toprol xl because their products were not dissolving properly  fda form edit in december  the fda issues a form  letter over concerns discovered during an inspection of its srikakulam facility no specific violations were mentioned in the letter key peopleedit as of  march   board members and senior executives included mr satish reddy  chairman mr gv prasad  cochairman  ceo mr ravi bhoothalingam  independent director mr anupam puri  independent director dr omkar goswami  independent director dr jp moreau  independent director ms kalpana morparia  independent director dr bruce la carter  independent director dr ashok ganguly  independent director mr sridar iyengar  independent director key productsedit top active pharmaceutical ingredientsedit ciprofloxacin hydrochloride ramipril terbinafine hci ibuprofen sertaline hydrochloride ranitidine hci form  naproxen sodium naproxen atorvastatin montelukast losartan potassium sparfloxacin nizatidine fexofenadine ranitidine hydrochloride form  clopidogrel not in us due to  patent case omeprazole finasteride sumatriptan top brands by dr reddysedit this section does not cite any sources please help improve this section by adding citations to reliable sources unsourced material may be challenged and removed may  learn how and when to remove this template message north america india russia decitabine injection omez nise otc omeprazole mg omezdsr omez azacitidine nise ketorol metoprolol er stamlo cetrine zolendronic acid reclast reditux ciprolet fondaparinux fondared senade omeprazole dr razo sirdalud tacrolimus razod ibuclin atorvastatin atocor novigan otc fexo econorm femibion see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b drreddys laboratories ltd results   archived copy pdf archived from the original pdf on  may  retrieved    indias most trusted brands  archived from the original on  may    dr reddys laboratories  – marketreportscom  life sciences research report technology networks sudbury essex uk archived  january  at the wayback machineaccessed   dr reddys laboratories limited says not to sell any businessdj reuters news agency  march accessed  october   pfizer in talks to buy drl’s formulations business in india ndtv new delhi  february accessed  october   dr reddys develops generic version of pfizers lipitor business standard new delhi and mumbai  november accessed  october   pfizer sues dr reddy’s over cholesterol drug ‘lipitor’  stock watch mumbai  november accessed  october   astrazeneca partners with indias torrent pharmaceuticals pharmaceutical technology iselin nj and chester uk archived  july  at the wayback machineaccessed  october   dr reddys laboratories will no longer produce its medicines in russia – pravdaru  february accessed   httpinreuterscomarticleucbsadrreddysdealsidinkbnmshk  httpwwwlivemintcomcompaniesbcrfqvlenfoouydqawmdrreddysentersintoinlicensingpactwithusbasedxenophtml  dr reddy’s receives exclusive rights for zocor archived  february  at the wayback machine  httphealtheconomictimesindiatimescomnewspharmadrreddyslaunchespurplehealth  a b httptimesofindiaindiatimescombusinessindiabusinessdrreddyslaunchespatientfriendlypackagingoncertainmedicinesarticleshowcms  a b httpwwwthehindubusinesslinecomcompaniesdrlrollsoutpatientcentricpurplehealthinitiativearticleecerefwlnews  a b perlecan highlights rd travails of indian pharma   october accessed   drl moving research arm to bangalore unit  may  accessed   recall notice listserv california board of pharmacy  june   httpwwwfiercepharmamanufacturingcomstoryfdaslapsdrreddysform  httpwwwinpharmatechnologistcomingredientsdrreddysapiplantreceivesusfdawithnineobservations  httpwwwdrreddyscomourstoryleadershipboardofdirectors external linksedit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra  mahindra tafe tata motors tvs aerospace  defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti dcm essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw lt lanco mahindra muthoot murugappa rpsanjiv goenka group ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways spicejet goair consumer goods  retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages patanjali ayurved emami energy  natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci vedanta limited suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu  kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical  biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr reddys idpl iil lupin sun pharmaceutical manufacturing  heavy industries acc ambuja apollo tyres asian paints ltd bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mittal steel company mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media zee entertainment enterprises telecommunications aircel airtel bsnl idea cellular jio micromax mobile mtnl reliance communications tata communications benchmark fy  revenues of over us  billion v t e cnx nifty companies of india acc ambuja cements asian paints ltd axis bank bajaj auto bank of baroda bhel bpcl bharti airtel cairn india cipla coal india dlf dr reddys laboratories gail grasim industries hcl technologies hdfc hdfc bank hero motocorp hindalco industries hul infosys icici bank idfc indusind bank ltd itc limited jindal steel and power kotak mahindra bank lt lupin mahindra  mahindra maruti udyog nmdc ntpc ongc power grid corporation pnb reliance industries sesa sterlite limited sbi sun pharmaceutical tcs tata motors tata power tata steel tech mahindra ultratech cement wipro zee entertainment enterprises retrieved from httpsenwikipediaorgwindexphptitledrreddyslaboratoriesoldid categories companies listed on the new york stock exchangepharmaceutical companies of indiacompanies based in hyderabad indiacompanies listed on the bombay stock exchangemultinational companies headquartered in indiaindian companies established in cnx niftypharmaceutical companies established in indian brandshidden categories webarchive template wayback linksengvarb from january use dmy dates from january pages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from september articles needing additional references from may all articles needing additional references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages العربيةdeutschفارسیfrançaisहिन्दीಕನ್ನಡromânăрусскийதமிழ்తెలుగుtiếng việt edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view dr reddys laboratories  wikipedia dr reddys laboratories from wikipedia the free encyclopedia jump to navigation search rdy redirects here for the radar system see radar doppler multitarget dr reddys laboratories type public traded as nse drreddy bse  nyse rdy industry pharmaceuticals founded  founders kallam anji reddy headquarters hyderabad telangana india key people g v prasad ceo kallam satish reddy chairman revenue ₹ crore us billion  net income ₹ crore us million  total assets ₹ crore us billion  total equity ₹ crore us million  number of employees  april  website wwwdrreddyscom dr reddys laboratories is an indian multinational pharmaceutical company based in hyderabad telangana india the company was founded by anji reddy who previously worked in the mentor institute indian drugs and pharmaceuticals limited of hyderabad india dr reddys manufactures and markets a wide range of pharmaceuticals in india and overseas the company has over  medications  active pharmaceutical ingredients apis for drug manufacture diagnostic kits critical care and biotechnology products dr reddys began as a supplier to indian drug manufacturers but it soon started exporting to other lessregulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the us food and drug administration fda by the early s the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in moredeveloped economies this allowed their movement into regulated markets such as the us and europe in  dr reddy laboratories was listed among  of indias most trusted brands according to the brand trust report  a study conducted by trust research advisory a brand analytics company by  dr reddys had six fda plants producing active pharmaceutical ingredients in india and seven fdainspected and iso  quality and iso  environmental management certified plants making patientready medications – five of them in india and two in the uk in  the familycontrolled dr reddys denied that it was in talks to sell its generics business in india to us pharmaceutical giant pfizer which had been suing the company for alleged patent infringement after dr reddys announced that it intended to produce a generic version of atorvastatin marketed by pfizer as lipitor an anticholesterol medication reddys was already linked to uk pharmaceuticals multinational glaxo smithkline contents  company history  international expansion  new drug discovery  expansion and acquisition  american ipo and expansion into europe  global expansion  patientcentric initiatives  issues and recalls  drug discovery problems   recall   fda form   key people  key products  top active pharmaceutical ingredients  top brands by dr reddys  see also  references  external links company historyedit dr reddys originally launched in  producing active pharmaceutical ingredients in  reddys started operations on branded formulations within a year reddys had launched norilet the companys first recognized brand in india soon dr reddys obtained another success with omez its branded omeprazole – ulcer and reflux oesophagitis medication – launched at half the price of other brands on the indian market at that time within a year reddys became the first indian company to export the active ingredients for pharmaceuticals to europe in  reddys started to transform itself from a supplier of pharmaceutical ingredients to other manufacturers into a manufacturer of pharmaceutical products international expansionedit the companys first international move took it to russia in  there dr reddys formed a joint venture with the countrys biggest pharmaceuticals producer biomed they pulled out in  amid accusations of scandal involving a significant material loss due to the activities of moscows branch of reddys labs with the help of biomeds chief executive reddys sold the joint venture to the kremlinfriendly sistema group in  reddys entered into a joint venture in the middle east and created two formulation units there and in russia reddys exported bulk drugs to these formulation units which then converted them into finished products in  reddys started targeting the us generic market by building state of art manufacturing facilitycitation needed new drug discoveryedit biopharma finished dosage unit iii in hyderabad biopharma finished dosage unit i in hyderabad reddys path into new drug discovery involved targeting speciality generics products in western markets to create a foundation for drug discovery development of speciality generics was an important step for the companys growing interest in the development of new chemical entities the elements involved in creating a speciality generic such as innovation in the laboratory developing the compound and sending the sales team to the market are also stages in the development of a new specialty drug starting with speciality generics allowed the company to gain experience with those steps before moving on to creating brandnew drugs reddys also invested heavily in establishing rd labs and is the only indian company to have significant rd being undertaken overseas dr reddys research foundation was established in  and in order to do research in the area of new drug discovery at first the foundations drug research strategy revolved around searching for analogues focus has since changed to innovative rd hiring new scientists especially indian students studying abroad on doctoral and postdoctoral courses in  the foundation set up an american laboratory in atlanta dedicated to discovery and design of novel therapeutics the laboratory is called reddy us therapeutics inc rusti and its main aim is the discovery of nextgeneration drugs using genomics and proteomics reddys research thrust focused on large niche areas in western markets – anticancer antidiabetes cardiovascular and antiinfection drugscitation needed reddys international marketing successes were built on a strong manufacturing base which itself was a result of inorganic growth through acquisition of international and national facilities reddys merged cheminor drug limited cdl with the primary aim of supplying active pharmaceutical ingredients to the technically demanding markets of north america and europe this merger also gave reddys an entry into the valueadded generics business in the regulated markets of apis apis in medicine expansion and acquisitionedit by  reddys made the transition from being an api and bulk drug supplier to regulated markets like the usa and the uk and a branded formulations supplier in unregulated markets like india and russia into producing generics by filing an abbreviated new drug application anda in the usa the same year reddys outlicensed a molecule for clinical trials to novo nordisk a danish pharmaceutical company it strengthened its indian manufacturing operations by acquiring american remedies ltd in  this acquisition made reddy’s the third largest pharmaceutical company in india after ranbaxy and glaxo i ltd with a full spectrum of pharmaceutical products which included bulk drugs intermediates finished dosages chemical synthesis diagnostics and biotechnologycitation needed reddy’s started exploiting para  filing as a strategy in bringing new drugs to the market at a faster pace in  it submitted a para  application for omeprazole the drug that had been the cornerstone of its success in india in december  reddy’s had undertaken its first commercial launch of a generic product in the usa and its first product with market exclusivity was launched there in august  the same year it also became the first nonjapanese pharmaceutical company from the asiapacific region to obtain a new york stock exchange listing groundbreaking achievements for the indian pharmaceutical industrycitation needed in  reddy’s became the first indian company to launch the generic drug fluoxetine a generic version of eli lilly and company’s prozac with day market exclusivity in the usa prozac had sales in excess of  billion per year in the late s barr laboratories of the us obtained exclusivity for all of the approved dosage forms  mg  mg except one  mg which was obtained by reddy’s lilly had numerous other patents surrounding the drug compound and had already enjoyed a long period of patent protection the case to allow generic sales was heard twice by the federal circuit court and reddy’s won both hearings reddy’s generated nearly  million in revenue during the initial sixmonth exclusivity period with such high returns at stake reddy’s was gambling on the success of the litigation failure to win the case could have cost them millions of dollars depending on the length of the trial the fluoxetine marketing success was followed by the american launch of reddys housebranded ibuprofen tablets in   and  mg strengths in january  direct marketing under the reddy’s brand name represented a significant step in the company’s efforts to build a strong and sustainable us generic business it was the first step in building reddy’s fullyfledged distribution network in the us marketcitation needed in  dr reddys laboratories bought the established brands of belgian drugmaker ucb sa in south asia for  billion rupees  million dr reddys laboratories also signed a licensing pact with xenoport for their experimental treatment to treat plaque psoriasis as per the agreement dr reddy’s will be granted exclusive us rights to develop and commercialize xp for all indications for an upfront payment of  million american ipo and expansion into europeedit in  reddy’s completed its us initial public offering of  million secured by american depositary receipts at that time the company also became listed on the new york stock exchange funds raised from the initial public offering helped reddy’s move into international production and take over technologybased companies in  reddy’s started its european operations by acquiring two pharmaceutical firms in the united kingdom the acquisition of bms laboratories and its wholly owned subsidiary meridian uk allowed reddy’s to expand geographically into the european market in  reddy’s also invested  million usd in equity capital into bio sciences ltd auriegene discovery technologies a contract research company was established as a fully owned subsidiary of reddy’s in  auriegenes objective was to gain experience in drug discovery through contract research for other pharmaceutical companies reddy’s entered into a venture investment agreement with icici bank an established indian banking company under the terms of the agreement icici venture agreed to fund the development registration and legal costs related to the commercialization of andas on a predetermined basis upon commercialization of these products dr reddys pays icici venture royalty on net sales for a period of  years global expansionedit the company elected to expand globally and acquired other entities in march  dr reddy’s acquired bms laboratories beverley and its wholly owned subsidiary meridian healthcare for  million euros these companies deal in oral solids liquids and packaging with manufacturing facilities in london and beverley in the uk recently dr reddy’s entered into an rd and commercialization agreement with argenta discovery ltd a private drug development company based in the uk for the treatment of chronic obstructive pulmonary disease copd dr reddy’s entered into a year agreement with rheoscience as of denmark for the joint development and commercialization of balaglitazone drf a molecule for the treatment of type diabetes rheoscience holds this product’s marketing rights for the european union and china while the rights for the us and the rest of the world will be held by dr reddy’s dr reddy’s conducted clinical trials of its cardiovascular drug rus  in belfast northern ireland in  the trials were conducted to study the safety and the pharmacokinetic profiles of the drug which is intended for the treatment of atherosclerosis a major cause of cardiovascular disorders dr reddy’s entered into a marketing agreement with eurodrug laboratories a pharmaceutical company based in netherlands for improving its product portfolio for respiratory diseases it introduced a secondgeneration xanthine bronchodilator doxofylline which is used for the treatment of asthma and copd patients in  reddy’s acquired trigenesis therapeutics inc a usbased private dermatology company this acquisition gave reddy’s access to proprietary products and technologies in the dermatology sector dr reddy’s para  application strategy for generic business received a severe setback when reddy’s lost the patent challenge in the case of pfizer’s drug norvasc amlodipine maleate a drug indicated for the treatment of hypertension and angina the cost involved in patent litigation as well as the unexpected loss of the patent challenge affected reddy’s plans to start speciality business in the us generic markets in march  dr reddy’s acquired betapharm arzneimittel gmbh from i for  million euros this is one of the largestever foreign acquisitions by an indian pharmaceutical company betapharm is germany’s fourthlargest generics pharmaceutical company with a  market share including  active pharmaceutical ingredients reddy’s has promoted india’s first integrated drug development company perlecan pharma pvt ltd together with icici ventures capital fund management company ltd and citigroup venture capital international growth partnership mauritius ltd the combined entity will undertake clinical development and outlicensing of new chemical entity assets dr reddys is presently licensed by merck  co to sell an authorized generic version of the popular drug simvastatin zocor in the usa since dr reddys has a license from merck it was not subject to the exclusivity period on generic simvastatin as of  dr reddy’s laboratories exceeded  million usd in revenues flowing from their apis branded formulations and generics segments the former two segments account for almost  of revenues dr reddys deals in and manages all the processes from the development of the api to the submission of finished dosage dossiers to the regulatory agencies patientcentric initiativesedit in september  dr reddy’s launched “purple health” in india a patient centric platform to deliver solutions that address unmet needs of patients purple health will address unmet needs of patients involving four segments awareness access access to medication adherence adherence to therapy and experience simplified medication experience the first step in this program will be the launch of new patient friendly packaging for its top  bestselling brands which will be rolledout in a phased manner over the next six months the packaging has been designed such that blister packs would have extra space for brand name which ensures easy identification at the pharmacy a tab at the bottom with expiry date clearly mentioned and a pictorial representation of the time the medicine needs to be taken in case of bottles the measuring cup is now easy to read and neck of the bottle has been modified to ensure minimal spillage purple health also includes patient support services for example someone taking medicines for an advanced kidney condition would be supported by messages and counselling on diet medicine and so on issues and recallsedit drug discovery problemsedit in september  dr reddys spun off its drug discovery and research wing into a separate company called perlecan pharma private limited at the time this was hailed as an innovative move but in  the company had to be wound down due to funding constraints dr reddys was the first indian pharma company to attempt such an effort to decouple risk of drug discovery from the parent company by creating a separate company with external source of funding perlecan pharma was partially funded by icici venture capital and citigroup venture international both of which held a  stake in perlecan for an estimated  million however the company was forced to buy back the perlecan shares from icici and citigroup due to doubts regarding the commercial viability of the drug candidates that were in perlecans pipeline at that point perlecan became a wholly owned subsidiary in the board meeting of  october  the company chose to amalgamateabsorb perlecan thereby making it an inhouse research facility as it was before  in  the company did a uturn and has handed over discovery research and related intellectual property to its bangalorebased subsidiary with the possibility of spinning it off as a different entity altogether the company may be hoping to find a strategic partner in the future to share the risks and research funding  recalledit in june  certain lots of dr reddys generic simvastatin tablets were recalled due to tablets having a musty or moldy smell on june   the new york times published an article warning unheeded heart drugs are recalled in which it said another large indian manufacturer and dr reddys laboratories have announced recalls over the past two months totalling more than  bottles of a widely used heart drug toprol xl because their products were not dissolving properly  fda form edit in december  the fda issues a form  letter over concerns discovered during an inspection of its srikakulam facility no specific violations were mentioned in the letter key peopleedit as of  march   board members and senior executives included mr satish reddy  chairman mr gv prasad  cochairman  ceo mr ravi bhoothalingam  independent director mr anupam puri  independent director dr omkar goswami  independent director dr jp moreau  independent director ms kalpana morparia  independent director dr bruce la carter  independent director dr ashok ganguly  independent director mr sridar iyengar  independent director key productsedit top active pharmaceutical ingredientsedit ciprofloxacin hydrochloride ramipril terbinafine hci ibuprofen sertaline hydrochloride ranitidine hci form  naproxen sodium naproxen atorvastatin montelukast losartan potassium sparfloxacin nizatidine fexofenadine ranitidine hydrochloride form  clopidogrel not in us due to  patent case omeprazole finasteride sumatriptan top brands by dr reddysedit this section does not cite any sources please help improve this section by adding citations to reliable sources unsourced material may be challenged and removed may  learn how and when to remove this template message north america india russia decitabine injection omez nise otc omeprazole mg omezdsr omez azacitidine nise ketorol metoprolol er stamlo cetrine zolendronic acid reclast reditux ciprolet fondaparinux fondared senade omeprazole dr razo sirdalud tacrolimus razod ibuclin atorvastatin atocor novigan otc fexo econorm femibion see alsoedit biotech and pharmaceutical companies in the new york metropolitan area referencesedit  a b drreddys laboratories ltd results   archived copy pdf archived from the original pdf on  may  retrieved    indias most trusted brands  archived from the original on  may    dr reddys laboratories  – marketreportscom  life sciences research report technology networks sudbury essex uk archived  january  at the wayback machineaccessed   dr reddys laboratories limited says not to sell any businessdj reuters news agency  march accessed  october   pfizer in talks to buy drl’s formulations business in india ndtv new delhi  february accessed  october   dr reddys develops generic version of pfizers lipitor business standard new delhi and mumbai  november accessed  october   pfizer sues dr reddy’s over cholesterol drug ‘lipitor’  stock watch mumbai  november accessed  october   astrazeneca partners with indias torrent pharmaceuticals pharmaceutical technology iselin nj and chester uk archived  july  at the wayback machineaccessed  october   dr reddys laboratories will no longer produce its medicines in russia – pravdaru  february accessed   httpinreuterscomarticleucbsadrreddysdealsidinkbnmshk  httpwwwlivemintcomcompaniesbcrfqvlenfoouydqawmdrreddysentersintoinlicensingpactwithusbasedxenophtml  dr reddy’s receives exclusive rights for zocor archived  february  at the wayback machine  httphealtheconomictimesindiatimescomnewspharmadrreddyslaunchespurplehealth  a b httptimesofindiaindiatimescombusinessindiabusinessdrreddyslaunchespatientfriendlypackagingoncertainmedicinesarticleshowcms  a b httpwwwthehindubusinesslinecomcompaniesdrlrollsoutpatientcentricpurplehealthinitiativearticleecerefwlnews  a b perlecan highlights rd travails of indian pharma   october accessed   drl moving research arm to bangalore unit  may  accessed   recall notice listserv california board of pharmacy  june   httpwwwfiercepharmamanufacturingcomstoryfdaslapsdrreddysform  httpwwwinpharmatechnologistcomingredientsdrreddysapiplantreceivesusfdawithnineobservations  httpwwwdrreddyscomourstoryleadershipboardofdirectors external linksedit official website v t e major indian companies economy of india list of companies of india automotive ashok leyland bajaj auto eicher motors hero motocorp hindustan motors mahindra  mahindra tafe tata motors tvs aerospace  defence bharat electronics drdo hal ordnance factories conglomerates aditya birla adani avantha bajaj bharti dcm essar essel gmr godrej gvk hinduja itc jaypee jindal kirloskar jsw lt lanco mahindra muthoot murugappa rpsanjiv goenka group ramoji reliance adag reliance rpg sahara shapoorji pallonji sun tata tvs torrent ub videocon wadia civil aviation air india indigo jet airways spicejet goair consumer goods  retail britannia industries dabur flipkart future group godrej consumer hindustan unilever itc nirma reliance retail tata global beverages patanjali ayurved emami energy  natural resources bharat petroleum cairn india chennai petroleum coal india gail essar oil hindustan petroleum indian oil corporation national aluminum nhpc nmdc nlc ntpc oil india ongc power finance power grid rinl reliance infrastructure recl sci vedanta limited suzlon energy tata power finance andhra bank axis bank bank of baroda bank of india canara bank central bank of india hdfc bank icici bank idbi bank ing vysya bank jammu  kashmir bank kotak mahindra bank lic mudra bank muthoot finance ltd punjab national bank sbi tamilnad mercantile bank union bank of india yes bank healthcare pharmaceutical  biotech aurobindo pharma cadila healthcare cipla glenmark pharmaceuticals dr reddys idpl iil lupin sun pharmaceutical manufacturing  heavy industries acc ambuja apollo tyres asian paints ltd bengal chemicals and pharmaceuticals bhushan bhel dlf gammon india havells hcc hindalco india cements jindal steel jsw mittal steel company mrf sail tata steel ultratech information technology hcl technologies infosys tata consultancy services tech mahindra wipro media sun group the times group living media zee entertainment enterprises telecommunications aircel airtel bsnl idea cellular jio micromax mobile mtnl reliance communications tata communications benchmark fy  revenues of over us  billion v t e cnx nifty companies of india acc ambuja cements asian paints ltd axis bank bajaj auto bank of baroda bhel bpcl bharti airtel cairn india cipla coal india dlf dr reddys laboratories gail grasim industries hcl technologies hdfc hdfc bank hero motocorp hindalco industries hul infosys icici bank idfc indusind bank ltd itc limited jindal steel and power kotak mahindra bank lt lupin mahindra  mahindra maruti udyog nmdc ntpc ongc power grid corporation pnb reliance industries sesa sterlite limited sbi sun pharmaceutical tcs tata motors tata power tata steel tech mahindra ultratech cement wipro zee entertainment enterprises retrieved from httpsenwikipediaorgwindexphptitledrreddyslaboratoriesoldid categories companies listed on the new york stock exchangepharmaceutical companies of indiacompanies based in hyderabad indiacompanies listed on the bombay stock exchangemultinational companies headquartered in indiaindian companies established in cnx niftypharmaceutical companies established in indian brandshidden categories webarchive template wayback linksengvarb from january use dmy dates from january pages using deprecated image syntaxall articles with unsourced statementsarticles with unsourced statements from september articles needing additional references from may all articles needing additional references navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages العربيةdeutschفارسیfrançaisहिन्दीಕನ್ನಡromânăрусскийதமிழ்తెలుగుtiếng việt edit links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view greddy search by part  part                    b             x            x                                      x       x                             x      x                                     x x                      x                                                                                                                 x                                                                     a                                                                                                                                                                                                                                                                             x                                                 b                                                  ts    ts                                                                                                                             x x x        x x x x         x x   x x         x x x                                                                                                                                ts ts                                                                                                                                                                                                                                                                                                                                        ts ts ts ts ts ts                                  zeuk mmgas  a    bensopra bovgasket bs bs bsx bsx bsx bs bsbob call dycanard glvblk glvgry grw grw grw griapp gservdct gservtcm gt gt gt gt gt gt gt gt gt gt gt gt gt gtps lic r gk dm r gs dm r sgs dm r cpm dm r csk dm r css dm r do dm r fwcfl dm r fwdch dm r fwdcp dm r gl dm r gp dm r gp dm r mc dm r mc  dm r mc o dm r opk dm r tf dm rbgba rbgbb rbgbc rbgf rbgf rbgj rbgj rbgk rbgk rbgk rbgs rbgs rbgs rbgs rbgs rbgs rbnt rbnt rcfrs sa sa sa sa sa sa sa sa sa sa sa sa shopgreddy shopgreddy shopgreddy shopgreddy susevool tba tba tba tba tba tbaevo tceuk txrb txrb vrbtpis vrcnchd vrcrod vrfgpis vrlong vrshort products total tuneup exhaust all exhaust greddy supreme  sp greddy revolution  rs greddy evolution gt greddy titanium offroad exhaust part air intake greddy airinx kits greddy airinx parts turbochargers greddy turbo kits greddy blowoff valves greddy hard piping kits greddy wastegates greddy turbochargers  misc cooling greddy intercooler kits greddy oil cooler kits greddy oil block adapters greddy radiator breather tank engine  drivetrain greddy intake manifolds greddy oil pan greddy oil catch tank greddy oil filter greddy differential covers greddy timing belts greddy pulley kits greddy metal head gaskets electronics greddy profec boost controllers greddy sirius meter series greddy informeter touch greddy emanage gauge accessories suspension greddy x kw suspension aerodynamics greddy gracer aero parts rocket bunny  pandem aero kits accessories promotional items greddy shift knobs greddy racing lug nuts greddy carbon hood dampers greddy magnetic oil drain plug greddy radiator caps featured vehicles frs  brz   nissan vrdett r gtr nissan rbdett r gtr nissan srdet sss silvia sx other jdm greddy items boost brigade online store tech support exhaust registration exhaust information air intake systems suspension turbo kits intercoolers turbo related profec boost control emanage turbo timers misc electronics informeter meters  gauges intake manifold aero kits contact greddy authorized dealers links home  total tuneup total tuneup founded and maintained by enthusiast for enthusiast greddy performance products has continued to be committed to delivering useful quality aftermarket performance products to the tuning fan from the begins in japan of trust company ltd in  we have continued to aim to provide a complete array of performance products to maximize the excitement and enjoyment you get from your vehicle we use our concept of the total tuneup to design and innovate products to enhance other products thus exponentially increasing the fun of your driving experience exhaust all exhaust greddy supreme  sp greddy revolution  rs greddy evolution gt greddy titanium offroad exhaust part air intake greddy airinx kits greddy airinx parts turbochargers greddy turbo kits greddy blowoff valves greddy hard piping kits greddy wastegates greddy turbochargers  misc cooling greddy intercooler kits greddy oil cooler kits greddy oil block adapters greddy radiator breather tank engine  drivetrain greddy intake manifolds greddy oil pan greddy oil catch tank greddy oil filter greddy differential covers greddy timing belts greddy pulley kits greddy metal head gaskets electronics greddy profec boost controllers greddy sirius meter series greddy informeter touch greddy emanage gauge accessories suspension greddy x kw suspension aerodynamics greddy gracer aero parts rocket bunny  pandem aero kits accessories promotional items greddy shift knobs greddy racing lug nuts greddy carbon hood dampers greddy magnetic oil drain plug greddy radiator caps featured vehicles frs  brz   nissan vrdett r gtr nissan rbdett r gtr nissan srdet sss silvia sx other jdm greddy items navigate disclaimer     warranty products     online store     greddy outlet     tech support     contact greddy     authorized dealers     blog amazonincustomer reviews basic structural analysis amazon try prime all all categories amazon fashion amazon global store amazon pantry appliances apps  games baby beauty books car  motorbike clothing  accessories computers  accessories electronics furniture garden  outdoors gift cards grocery  gourmet foods health  personal care home  kitchen industrial  scientific jewellery kindle store luggage  bags luxury beauty movies  tv shows music musical instruments office products pet supplies shoes  handbags software sports fitness  outdoors tools  home improvement toys  games used  refurbished video games watches go shop bycategory hello sign inyour orderstryprimeyourlists cart your amazonintodays dealsamazon paysellcustomer service basic structural analysis › customer reviews customer reviews out of  stars out of  stars star star star star starbasic structural analysisbyc s reddy price₹  write a reviewadd to cartadd to wish list this page works best with javascript disabling it will result in some disabled or missing features you can still see all customer reviews for the product sort by topmost recenttopfilter by all reviewersverified purchase onlyall reviewersall stars star only star only star only star only star onlyall positiveall criticalall starssearchthere was a problem filtering reviews right now please try again later out of  starsfive starsbyshovandip karanon  june verified purchasegood enoughcommentwas this review helpful to youyesnoreport abusecommentinsert product linkpaste the products web address belowproduct not found only products offered on amazon can be linkedselect whats thiswhat are product linksin the text of your review you can link directly to any product offered on amazonin to insert a product link follow these steps  find the product you want to reference on amazonin  copy the web address of the product  click insert product link paste the web address in the box  click select selecting the item displayed will insert text that looks like this asinxhamlet the pelican shakespeare  when your review is displayed on amazonin this text will be transformed into a hyperlink like so hamlet the pelican shakespeareyou are limited to  product links in your review and your link text may not be longer than  characters please write at least one wordyou must purchase at least one item from amazon to post a commenta problem occurred while submitting your comment please try again latersign in to comment showing  of  commentssort by newest oldest there was a problem loading comments right now please try again later out of  starsits a little tough and hot subject to touch byjishnu sajion  november verified purchaseits a little tough and hot subject to touch this helps  but you need to spend too much time commentwas this review helpful to youyesnoreport abusecommentinsert product linkpaste the products web address belowproduct not found only products offered on amazon can be linkedselect whats thiswhat are product linksin the text of your review you can link directly to any product offered on amazonin to insert a product link follow these steps  find the product you want to reference on amazonin  copy the web address of the product  click insert product link paste the web address in the box  click select selecting the item displayed will insert text that looks like this asinxhamlet the pelican shakespeare  when your review is displayed on amazonin this text will be transformed into a hyperlink like so hamlet the pelican shakespeareyou are limited to  product links in your review and your link text may not be longer than  characters please write at least one wordyou must purchase at least one item from amazon to post a commenta problem occurred while submitting your comment please try again latersign in to comment showing  of  commentssort by newest oldest there was a problem loading comments right now please try again later out of  starsfour starsbyarif janbaaz naimion  november verified purchaseits a nice book with good approach theory and nice numericalscommentwas this review helpful to youyesnoreport abusecommentinsert product linkpaste the products web address belowproduct not found only products offered on amazon can be linkedselect whats thiswhat are product linksin the text of your review you can link directly to any product offered on amazonin to insert a product link follow these steps  find the product you want to reference on amazonin  copy the web address of the product  click insert product link paste the web address in the box  click select selecting the item displayed will insert text that looks like this asinxhamlet the pelican shakespeare  when your review is displayed on amazonin this text will be transformed into a hyperlink like so hamlet the pelican shakespeareyou are limited to  product links in your review and your link text may not be longer than  characters please write at least one wordyou must purchase at least one item from amazon to post a commenta problem occurred while submitting your comment please try again latersign in to comment showing  of  commentssort by newest oldest there was a problem loading comments right now please try again later customers also viewed these itemsstructural analysis  vol  byss bhavikatti₹  out of  starsstructural analysis ebyhibbeler₹  out of  starsbasic and applied soil mechanicsbygopal ranjan₹  out of  starsrcc designsbybc punmia₹  out of  starswater supply engineering environmental engineering v bys k garg out of  starsneed customer service click here‹ see all details for basic structural analysis unlimited free fast delivery video streaming  more prime members enjoy free oneday and twoday delivery on eligible items unlimited video streaming minute early access to top deals  more  get started your recently viewed items and featured recommendations › view or edit your browsing history after viewing product detail pages look here to find an easy way to navigate back to pages you are interested in your recently viewed items and featured recommendations › view or edit your browsing history after viewing product detail pages look here to find an easy way to navigate back to pages you are interested in back to top get to know usabout uscareerspress releasesamazon caresgift a smileconnect with usfacebooktwitterinstagrammake money with ussell on amazonbecome an affiliatefulfilment by amazonadvertise your productsamazon pay on merchantsbecome an authorlet us help youyour accountreturns centre purchase protectionamazon assistanthelp australiabrazilcanadachinafrancegermanyitalyjapanmexiconetherlandsspainunited kingdomunited states abebooks books art  collectibles amazon web services scalable cloud computing services audible download audio books dpreview digital photography imdb movies tv  celebrities jungleecom shop online in india   lookcom kids clothing  shoes shopbop designer fashion brands amazon business everything for your business souqcom shop online in the middle east amazon now free hour delivery on everyday items   conditions of use  saleprivacy noticeinterestbased ads  amazoncom inc or its affiliates dr reddy’s in usa our story dr reddy’s in usa our products prescription overthecounter otc cpsia certificates life at dr reddys why work with us our people career customer service authorized distributors of record return goods policy compliance declaration contact us key contacts medical information our story dr reddy’s in usa dr reddy’s in usa each of us at dr reddy’s in usa is driven by the urgent need for more affordable innovative medications we are in the business of good health determined in our eﬀorts to accelerate access to these much needed medicines with every product launch we’re making healthcare more affordable while delivering value to the pharmacy like never before today there are millions of people who have beneﬁted from the medicines we have made our products span across major therapeutic categories including gastrointestinal cardiovascular pain management oncology antiinfectives pediatrics and dermatology a variety of forms including tablets capsules injectables and topical creams are available in addition an evergrowing product pipeline delivers the promise of even more lifechanging medicines in the future as emerging formulations and advanced therapeutics become available in the future dr reddy’s will continue to build one of the largest oﬀerings in the industry and bring value to the pharmacy and its customers driven by the urgency and increasing need for good health we are committed to improving access to medications across the united states c n reddy  abebooks abebookscom passion for books sign onmy accountbasket help search by keyword by title by author by isbn by publisher by collection find advanced search item added to your basket view basket order total  item items shipping destination proceed to basket view basket continue shopping c n reddy you searched for keywords c n reddy edit your search results    of       › sort by  author az author za bookseller rating highest price lowest price lowest total price most recently listed relevance beta title az title za year of publication ascending year of publication descending show results for product type all product types books  magazines  periodicals  comics sheet music art prints  posters photographs maps manuscripts  paper collectibles refine by condition all conditions new books  used books  binding all bindings hardcover  softcover  collectible attributes first edition  signed copy  dust jacket  sellersupplied images  not printed on demand free shipping free us shipping  bookseller location all locations select a country select a country canada france germany india italy usa united kingdom bookseller rating all booksellers and up  and up  and up     search within these results stock image operating systems made easy c madana kumar reddy published by usplaxmi publications p ltd new delhi  isbn   isbn   new first edition quantity available  from books in my basket new delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description usplaxmi publications p ltd new delhi  na book condition new first pp bookseller inventory   more information about this seller  ask bookseller a question  yanadi response to change an attempt in action anthropology binod c agrawal n sudhakar rao and pc gurivi reddy used quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description this is a book on action anthropology which narrates and evaluates the manner in which change was brought into the life of the yanadi who in the year  were still using stone age methods for making fire the juxtaposition of space age technology and primitivism at sriharikota is brought out very effectively in the day to day interaction between the anthropologists the shar administration and the yanadi inhabitants whose lives were undergoing a major transformation here significantly enough the anthropologist emerges not as an expert or consultant but as a fellow human who gathers facts diagnoses day to day problems suggests strategies and helps in actualizing suggested solutions his role is thus an enlarged one which demands his cooperation understanding and total involvement in order to achieve the desired goals the book manages to bet behind the scenes of a unique and highly successful experience which could serve as a model for an experimental approach particularly in the context of the establishment of large industrial undertakings in remote and inaccessible tribal areas in india and elsewhere planners administrations in addition to anthropologists and sociologists would benefit from a perusal of this interesting experiment bookseller inventory  concept more information about this seller  ask bookseller a question  stock image yanadi response to change an attempt in action anthropology binod c agrawaln sudhakar raopc gurivi reddy published by concept publishing company p ltd  isbn   isbn   new hardcover quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description concept publishing company p ltd  hardcover book condition new this is a book on action anthropology which narrates and evaluates the manner in which change was brought into the life of the yanadi who in the year  were still using stone age methods for making fire the juxtaposition of space age technology and primitivism at sri harikota is brought out very effectively in the day to day interaction between the anthropologists the shar administration and the yanadi inhabitants whose lives were undergoing a major transformation here significantly enough the anthropologist emerges not as an expert or consultant but as a fellow human who gathers facts diagnoses day to day problems suggests strategies and helps in actualizing suggested solutions his role is thus an enlarged one which demands his cooperation understanding and total involvement in order to achieve the desired goals the book manages to bet behind the scenes of a unique and highly successful experience which could serve as a model for an experimental approach particularly in the context of the establishment of large industrial undertakings in remote and inaccessible tribal areas in india and elsewhere planners administrations in addition to anthropologists and sociologists would benefit from a perusal of this interesting experiment printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image renewable energy sources for fuels and electricity editorthomas b johansson editorhenry kelly editoramula k n reddy editorrobert williams contributoralan douglas poole contributorrichard l bain contributoral cavallo contributoreric d larson contributorisais c macedo contributorallen m barnett contributoreldon boes contributorsigurd wagner contributorcharles e wyman contributorken zweibel contributorjoan m ogden contributorsusan m hock contributorrichard dive contributordavid kearney contributorpascal de laquil contributorcarl j weinberg contributordon r smith contributorjoseph j iannucci contributordon j stevens contributorgautum dutt published by island press  isbn   isbn   used paperback quantity available  from ergodebooks richmond tx usa bookseller rating price us  convert currency shipping us  within usa destination rates  speeds item description island press  paperback book condition used good bookseller inventory  song more information about this seller  ask bookseller a question  yanadi response to change an attempt in action anthropology binod c agrawal n sudhakar rao and pc gurivi reddy used quantity available   from a  z books new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description this is a book on action anthropology which narrates and evaluates the manner in which change was brought into the life of the yanadi who in the year  were still using stone age methods for making fire the juxtaposition of space age technology and primitivism at sriharikota is brought out very effectively in the day to day interaction between the anthropologists the shar administration and the yanadi inhabitants whose lives were undergoing a major transformation here significantly enough the anthropologist emerges not as an expert or consultant but as a fellow human who gathers facts diagnoses day to day problems suggests strategies and helps in actualizing suggested solutions his role is thus an enlarged one which demands his cooperation understanding and total involvement in order to achieve the desired goals the book manages to bet behind the scenes of a unique and highly successful experience which could serve as a model for an experimental approach particularly in the context of the establishment of large industrial undertakings in remote and inaccessible tribal areas in india and elsewhere planners administrations in addition to anthropologists and sociologists would benefit from a perusal of this interesting experiment bookseller inventory  concept more information about this seller  ask bookseller a question  stock image yanadi response to change an attempt in action anthropology binod c agrawaln sudhakar raopc gurivi reddy published by concept publishing company p ltd  isbn   isbn   new hardcover quantity available   from a  z books new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description concept publishing company p ltd  hardcover book condition new this is a book on action anthropology which narrates and evaluates the manner in which change was brought into the life of the yanadi who in the year  were still using stone age methods for making fire the juxtaposition of space age technology and primitivism at sri harikota is brought out very effectively in the day to day interaction between the anthropologists the shar administration and the yanadi inhabitants whose lives were undergoing a major transformation here significantly enough the anthropologist emerges not as an expert or consultant but as a fellow human who gathers facts diagnoses day to day problems suggests strategies and helps in actualizing suggested solutions his role is thus an enlarged one which demands his cooperation understanding and total involvement in order to achieve the desired goals the book manages to bet behind the scenes of a unique and highly successful experience which could serve as a model for an experimental approach particularly in the context of the establishment of large industrial undertakings in remote and inaccessible tribal areas in india and elsewhere planners administrations in addition to anthropologists and sociologists would benefit from a perusal of this interesting experiment printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image national conference of environmental remediation science and technology  greensboro nc national conference on environmental remediation science and technolog g b reddy editor published by battelle pr  isbn   isbn   new hardcover quantity available  from ergodebooks richmond tx usa bookseller rating price us  convert currency shipping us  within usa destination rates  speeds item description battelle pr  hardcover book condition new bookseller inventory  dadax more information about this seller  ask bookseller a question  social studies of science  volume   number   august  revue social studies of science published by sage  social studies of science  used softcover quantity available  from librairie philoscience fercé sur sarthe france bookseller rating price us  convert currency shipping us  from france to usa destination rates  speeds item description sage  social studies of science  book condition etat  bon paperback in  vol   pages contents chapitres  peter buck  order and control the scientific method in china and in the united states  lyndsay a farrall  controversy and conflict in science a case study the english biometry school and mendels law  loren r graham  the formation of soviet research institutes a combination of revolutionary innovation and international borrowing  discussion paper  amulya kumar n reddy  alternative technology a viewpoint from india  notes and letters  lyle groeneveld norman koller and nicholas c mullins  the advisers of the united states national science foundation  maria luisa rodriguez sala de gomezgil  mexican adolescents image of the scientist  daryl e chubin  trusted assessorship in science a relation in need of data working copy from pierre thuillier many annotations at ink and pencil on the  first articles  bookseller inventory   more information about this seller  ask bookseller a question  stock image global terrorists and nuclear threats to us and indian democracies reddy krishna m dr published by the indian american friendship council usa  isbn   isbn   used softcover quantity available  from second story books abaa rockville md usa bookseller rating price us  convert currency shipping us  within usa destination rates  speeds item description the indian american friendship council usa  na vo vg  no dj soft wrappers spine with centered red lettering for title and full author aligned beneath in red gentle handled well bound without edgewear and a compact volume overall large red lettering centered at header and above bottom edge of panel between an earth graphic and rear covered with text commentary no spinal reading crease and just faint touch to softpanel perimeter loc stamp of previous owner in red on left fep as unread quality smooth off white within text interior unmarred and a clean bright copy with exterior edges neatly white  pp isbn  rockville bookseller inventory   more information about this seller  ask bookseller a question  stock image ageless mind and timeless ideas life and legend of koneru ramakrishna rao v balamohandas  kr rajani eds published by dk printworld p ltd new delhi india  isbn   isbn   new hardcover first edition quantity available   from munshiram manoharlal publishers pvt ltd new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description dk printworld p ltd new delhi india  hardcover book condition new dust jacket condition new first edition forewordsr bhatt prefacev bala mohan das and kr rajani  introductionkr rajani visuals part i  kr rao a knowledge dispenserb sambasiva prasad  magisterial and seminal work of kr raodavid lorimer  a model and an inspirationjp das  congratulations to my time twinstanley krippner  greetings to my spiritual brotherhiroshi motoyama  indias eminent contemporary philosopherlarry dossey  leader and pioneer in parapsychologysn arseculeratne  a complete academicc subba rao  a second leader for parapsychology in durham ncjohn g kruth  a visionary academichr nagendra  a sthitaprajna par excellencegc nayak part ii  k ramakrishna rao at andhra universityk samrajya lakshmi  kr raos academic journey of sixtyplus yearsv gowri rammohan  prof k ramakrishna rao and higher education reforms in indiaks chalam  a scholarly librarianc sasikala  explorer of new knowledge frontiersa prasanna kumar  a philosopherpsychologista lakshminath  a source of inspiration to younger generationkc reddy  padma shri prof k ramakrishna rao an appreciationcv raghavulu  an outstanding role modelsv sudhakar  born researcher and committed academiciank nirupa rani  my salutations to a great visionaryp nirmala devi  a preeminent academic leadery satyanarayana  teacher par excellence random reminiscencesgv raju  scholar and administratorallam appa rao  light of my professional careergvsl narasimharaju  rare kind of shashtipurtisurapaneni sri babu epilogue  indian psychology a case study of mahatma gandhik ramakrishna rao printed pages  size  x  cm bookseller inventory   more information about this seller  ask bookseller a question  stock image yanadi response to change agrawal binod c rao n sudhakar reddy pc gurivi published by concept publishing company isbn   isbn   new quantity available  from majestic books london  united kingdom bookseller rating price us  convert currency shipping us  from united kingdom to usa destination rates  speeds item description concept publishing company book condition new pp ix   bookseller inventory   more information about this seller  ask bookseller a question  stock image indian poetry in english birendra pandey ed published by atlantic publishers  distributors p ltd  isbn   isbn   new hardcover quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description atlantic publishers  distributors p ltd  hardcover book condition new this remarkable anthology consisting of twenty papers brings together under one cover the critical studies on most significant works of the leading indian poets writing in english today the poets discussed in this volume include daruwalla krs iyengar ak ramanujan niranjan mohanty sn tripathi p raja vikram seth rn sinha dh kabadi aurobindo t basudeo reddy and op bhatnagar important contributors are  dr ra singh gd barche dc chambial dr d ganasekaran dr kv raghupathi t raghavan dr ps radha and vibha agrawal this anthology covers the indian poetry in english till date printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image climate change and agriculture over india gslhv prasada rao ggsn rao  vum rao eds published by phi learning  isbn  x isbn   new softcover first edition quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description phi learning  softcover book condition new first edition global warming has led to climate change which in turn has led to frequent occurrence of floods droughts and cold and heat waves affecting the productivity of food grain in a large measure this book studies the effects of regional climate change on the agriculture sector in different states of india the book also discusses the impact of global warming on the agriculture sector across the world and describes in particular how climate changevariability is affecting rainfall temperature and land in various states of india it also suggests adaptation techniques which can be evolved to neutralize the adverse effects of climate change besides the text explains the need for weather risk management agromet advisory services weather insurance and the principles and practices of integrated watershed management through a consortium of approaches for mitigating the adverse impact of climate change in the semiarid tropics this book with contributions from experts in the field and edited by academics who are authority on the subject should prove to be extremely useful to undergraduate and postgraduate students of agriculture planners policy makers and administrators contents preface  weather extremes and food securitygslhv prasada rao  regional climate change impacts in indiaggsn rao avms rao m vanaja vum rao and ys ramakrishna  climate change and agriculture over keralagslhv prasada rao d alexander kn krishnakumar and cs gopakumar  climate change and agriculture over tamil naduv geethalakshmi and ga dheebakaran  climate change and agriculture over karnatakamb rajegowda bt ravindrababu na janardhanagowda and n jagadeesh  climate change and agriculture over northern karnatakah venkatesh k krishna kumar sg aski and sn kulkarni  climate change and agriculture over andhra pradeshd raji reddy g sreenivas and nrg varma  weather hazards on crops over maharashtrarn sabale  climate change and agriculture over maharashtradd mokashi jd jadhav and jr kadam  climate change and agriculture over chhattisgarhasras sastri somnath choudhary and sanjeev malaiya  climate change and agriculture over orissas pasupalak  climate change and agriculture over gujaratvyas pandey and hr patel  climate change and rainfed agroecosystems over madhya pradeshkk agrawal sd upadhyay and ap upadhyay  climate change and agriculture over west bengalsaon bannerjee and sa khan  climate variability and crop production over the arid rajasthanas rao  climate change and agriculture over eastern uttar pradeshpadmakar tripathi and ak singh  climate change and agriculture over assamkk nath and rl deka  implications of climatic change for sustainable agriculture in haryanadiwan singh surender singh and vum rao  climate change and agriculture over uttarakhandsk tripathi and b chintamanie  climate change and agriculture over punjabprabhjyotkaur and ss hundal  climate change and temperate horticulture over himachal pradeshmohan singh jangra and im sharma  climate change and agriculture over jammu and kashmirmk khushu mahender singh and anil sharma  weather risk management and weather insurancegslhv prasada rao vum rao and ggsn rao index printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image c programming for scientists and engineers with app rama n reddy published by jones and bartlett  isbn   isbn   new soft cover quantity available  from books in my basket new delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description jones and bartlett  soft cover book condition new bookseller inventory   more information about this seller  ask bookseller a question  stock image indian poetry in english birendra pandey ed published by atlantic publishers  distributors p ltd  isbn   isbn   new hardcover quantity available   from a  z books new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description atlantic publishers  distributors p ltd  hardcover book condition new this remarkable anthology consisting of twenty papers brings together under one cover the critical studies on most significant works of the leading indian poets writing in english today the poets discussed in this volume include daruwalla krs iyengar ak ramanujan niranjan mohanty sn tripathi p raja vikram seth rn sinha dh kabadi aurobindo t basudeo reddy and op bhatnagar important contributors are  dr ra singh gd barche dc chambial dr d ganasekaran dr kv raghupathi t raghavan dr ps radha and vibha agrawal this anthology covers the indian poetry in english till date printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image climate change and agriculture over india gslhv prasada rao ggsn rao  vum rao eds published by phi learning  isbn  x isbn   new softcover first edition quantity available   from a  z books new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description phi learning  softcover book condition new first edition global warming has led to climate change which in turn has led to frequent occurrence of floods droughts and cold and heat waves affecting the productivity of food grain in a large measure this book studies the effects of regional climate change on the agriculture sector in different states of india the book also discusses the impact of global warming on the agriculture sector across the world and describes in particular how climate changevariability is affecting rainfall temperature and land in various states of india it also suggests adaptation techniques which can be evolved to neutralize the adverse effects of climate change besides the text explains the need for weather risk management agromet advisory services weather insurance and the principles and practices of integrated watershed management through a consortium of approaches for mitigating the adverse impact of climate change in the semiarid tropics this book with contributions from experts in the field and edited by academics who are authority on the subject should prove to be extremely useful to undergraduate and postgraduate students of agriculture planners policy makers and administrators contents preface  weather extremes and food securityâgslhv prasada rao  regional climate change impacts in indiaâggsn rao avms rao m vanaja vum rao and ys ramakrishna  climate change and agriculture over keralaâgslhv prasada rao d alexander kn krishnakumar and cs gopakumar  climate change and agriculture over tamil naduâv geethalakshmi and ga dheebakaran  climate change and agriculture over karnatakaâmb rajegowda bt ravindrababu na janardhanagowda and n jagadeesh  climate change and agriculture over northern karnatakaâh venkatesh k krishna kumar sg aski and sn kulkarni  climate change and agriculture over andhra pradeshâd raji reddy g sreenivas and nrg varma  weather hazards on crops over maharashtraârn sabale  climate change and agriculture over maharashtraâdd mokashi jd jadhav and jr kadam  climate change and agriculture over chhattisgarhâasras sastri somnath choudhary and sanjeev malaiya  climate change and agriculture over orissaâs pasupalak  climate change and agriculture over gujaratâvyas pandey and hr patel  climate change and rainfed agroecosystems over madhya pradeshâkk agrawal sd upadhyay and ap upadhyay  climate change and agriculture over west bengalâsaon bannerjee and sa khan  climate variability and crop production over the arid rajasthanâas rao  climate change and agriculture over eastern uttar pradeshâpadmakar tripathi and ak singh  climate change and agriculture over assamâkk nath and rl deka  implications of climatic change for sustainable agriculture in haryanaâdiwan singh surender singh and vum rao  climate change and agriculture over uttarakhandâsk tripathi and b chintamanie  climate change and agriculture over punjabâprabhjyotkaur and ss hundal  climate change and temperate horticulture over himachal pradeshâmohan singh jangra and im sharma  climate change and agriculture over jammu and kashmirâmk khushu mahender singh and anil sharma  weather risk management and weather insuranceâgslhv prasada rao vum rao and ggsn rao index printed pages  bookseller inventory   more information about this seller  ask bookseller a question  bookseller image indian higher education at a crossroads hardcover khwaja m shahid and bhanu pratap pritam isbn   isbn   new hardcover quantity available   from gyan books pvt ltd delhi india bookseller rating price us  convert currency shipping free from india to usa destination rates  speeds item description  hardcover book condition new  hardcover about the book the book titled indian higher education at a crossroads edited by prof khwaja m shahid and bhanu pratap pritam has made an effort to locate the contemporary indian higher education from developmental chronology beginning with a stock of historical development of indian higher education and largely the colonial framework of higher education to the recent issues in management and administration has also been categorically placed some of the well known educationists of the country have also contributed their thoughts on higher education and its contemporary concerns the book has been categorized in various subthemes such as development of indian higher education policy issues in higher education contemporary and professional education economic perspectives in higher education excellence in higher education social concerns in higher education global perspectives in higher education and finally the editors of the book have also concluded with a chapter indian higher education a way forward the book expects to present t h e indian higher education fro m governance  administrative perspective before the reader about the author dr khwaja m shahid pro vice chancellor maulana azad national urdu university manu hyderabad has extensive combination of academia as well as administration presently he is associated with manuu whereas formerly he was associated with institute of secretarial training  management  as director and union public service commission  new delhi as joint secretary apart from these he has also served in a central university as registrar of jamia milia islama new delhi his doctoral work on management of higher education in india is an extensive piece of research in this sector besides he has also participated in several national and international conferences  seminars as speaker on management and administration in general and higher education in particular bhanu pratap pritam  assistant professor of education associated with maulana azad nationa l urdu university  hyderabad for last three years priortothis  he received his education from institutions such as banaras hindu university varanasi the english and foreign languages university hyderabad and national universit y of educational planning and administration  n u e pa  n e w d e l h i h i s r e s e a r c h experiences at nuep a contributed optimally in terms of his knowledge and understanding of higher education in general and teacher education in particular  content contents foreword  acknowledgements  list of contributors  introduction  developmentofindian higher education  historical development of higher education in india prof khwaja m shahid   issues in managing indian higher education prof khwaja m shahid  policyissues in higher education  management of higher education in india problems and prospects prof faizan mustafa   reforms in higher education facts and impacts k sudha rao   challenges to higher education in india prof dr dn reddy   taking higher education in india to the future  some thoughts prof sunaina singh  contemporaryhigher and professional education  growth and development of engineering education in india dr pradeep kumar choudhury   teacher education at a cross roads critical reflections from justice verma commission report bhanu pratap pritam   rashtriya uchchatar shiksha abhiyan a trajectory of indian higher education policy and implementation challenges bhanu pratap pritam and prof pf rahman  economic perspectives in higher education  fdi and public private partnership in higher education dr saneem fatima and syed ahmed saad   higher education in india service revolution and economic development dr h akther banu s mansoor rahman  syed samiuddin muzamil   higher education and its labour market aspects a review of selected issues and evidences from india dr fayaz ahmad bhat  exce bookseller inventory   more information about this seller  ask bookseller a question  the oxford companion to economics in india revised edition kaushik basu ed published by oxford university press new delhi india  new paperback quantity available  from munshiram manoharlal publishers pvt ltd new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description oxford university press new delhi india  paperback book condition new revised edition in todays complex and fast evolving environment understanding indias economy is not just an intellectual challenge but with the country emerging as a major global player also a requirement this unique volume the first comprehensive resource of its kind on the contemporary indian economy aims to address this need culled from the collective wisdom and experience of over  distinguished contributors that include economists business leaders policymakers and analysts the companion covers the evolution of the indian economy from relative obscurity to an emergent global force the more than  entries span the recent cover stories of indias high growth leadership in software and information technology and outsourcing success and also document the backwatersthe widespread poverty farmer suicides child labour and the large and impoverished informal sector that houses a majority of indias labour force the revised edition a testimonial to the dynamism that epitomizes the indian economy includes several new topics that have grown in significance since the first edition was planned and several revised entries on topics that have undergone rapid transformation during the short time since the first edition was written contributors  ak shiva kumar  a vaidyanathan  abhijit v banerjee  abhirup sarkar  aditya bhattacharjea  ajay mahal  ajay shah  ajit k ghose  ajit mishra  alaka malwade basu  amaresh bagchi  amartya sen  amitabh kundu  amitava bose  amiya kumar bagchi  amrita dhillon  anandita philipose  anindita pujari  anindya sen  anirvan banerji  anjini kochar  anup kumar sinha  anuradha bhasin  arindam banik  arindam dasgupta  arjun sengupta  arkadev chatterjea  arnab basu  arvind panagariya  arvind subramanian  arvind virmani  asani sarkar  ashima goyal  ashok v desai  ashok guha  ashok gulati  ashok kotwal  ashok lahiri  ashok mitra  ashwini deshpande  asim k dasgupta  basudeb chaudhuri  bharat ramaswami  bhargavi rao  bhaskar dutta  bibek debroy  bimal jalan  bina agarwal  bpr vithal  charan singh  cnr rao  c rammanohar reddy  d narayana  david e bloom  deb kusum das  deena khatkhate  deepak nayyar  devesh kapur  dhushyanth raju  dilip mookherjee  dilip m nachane  dilip subramanian  dipjyoti majumdar  divya minisandram  e somanathan  esther duflo  g balachandran  gary s fields  gayatri ambika menon  gurcharan das  hèlène chevrousèvèrac  hiranya mukhopadhayay  ignatius chithelen  ila patnaik  indrani gupta  ira n gang  isher judge ahluwalia  jaivir singh  jayashree watal  jayati sarkar  jean dreze  jeemol unni  jeffrey hammer  jishnu das  jugnu bagga  kl krishna  k navaneetham  ks krishnaswamy  k seeta prabhu  kaivan munshi  kala seetharam sridhar  kameshwari shankar  kanhaiya singh  kanti bajpai  karthik muralidharan  kaushik ranjan bandyopadhyay  laveesh bhandari  ms swaminathan  madhura swaminathan  maitreesh ghatak  mandar p oak  mausumi das  medha malik kudaisya  mihir pandey  mihir rakshit  milind kandlikar  mirai chatterjee  mohammed zakaria siddiqui  monica das gupta  montek s ahluwalia  mrinal datta chaudhuri  mukesh anand  mukesh eswaran  mukesh gulati  nr narayana murthy  nagesh kumar  nancy chau  narendra jadhav  nirvikar singh  nitin desai  omkar goswami  p chidambaram  pami dua  pankaj chandra  partha ray  parthasarathi shome  payal malik  pc kesavan  prabhat patnaik  pradip k bhaumik  pranab bardhan  prasanta k pattanaik  pratap bhanu mehta  prital sailesh kadakia  pulin nayak  puran b mongia  r nagaraj  ra mashelkar  rk pachauri  rs deshpande  rafiq dossani  raghav gaiha  rajesh chakrabarti  rajnish mehra  ram singh  ramprasad sengupta  ranjan ray  rashmi banga  ratan tata  ravi kanbur  reema nanavaty  renana jhabvala  ritu anand  roger jeffery  rohini pande  rohini somanathan  ronald j bookseller inventory   more information about this seller  ask bookseller a question  stock image the independence day association of harlem celebration  classic reprint paperback unknown author published by forgotten books united states  isbn  x isbn   new paperback quantity available  from the book depository us london united kingdom bookseller rating print on demand price us  convert currency shipping free from united kingdom to usa destination rates  speeds item description forgotten books united states  paperback book condition new language english  brand new book  print on demand  excerpt from the independence day association of harlem celebration  it is earnestly hoped that you will make a special effort to be present and that we may show that the patriotic memories and glories associated with the nation s birthday have not yet faded out a large and enthusiastic meeting was held resulting in the determination to make an effort for the purpose of redeeming at least one section of our city from the reproach which the neglect to celebrate our country s birthday was bringing upon our people the independence day association of harlem was formed with capt a m underhill as president j h bogart as secretary and a n brockway m d as treasurer an executive committee was organized by the election of charles w dayton as chairman hon henry p mcgown as vicechairman and capt william c reddy as secretary about the publisher forgotten books publishes hundreds of thousands of rare and classic books find more at this book is a reproduction of an important historical work forgotten books uses stateoftheart technology to digitally reconstruct the work preserving the original format whilst repairing imperfections present in the aged copy in rare cases an imperfection in the original such as a blemish or missing page may be replicated in our edition we do however repair the vast majority of imperfections successfully any imperfections that remain are intentionally left to preserve the state of such historical works bookseller inventory  apc more information about this seller  ask bookseller a question  stock image managerial economics  financial analysis cr reddy published by acme learning pvtltd new delhi isbn  x isbn   new quantity available  from books in my basket new delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description acme learning pvtltd new delhi na book condition new bookseller inventory   more information about this seller  ask bookseller a question  stock image plain speaking on democratic reforms politics of social justice police encounters challenges of terrorism crc reddy published by aph publishing corporation new delhi  isbn   isbn   new quantity available  from books in my basket new delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description aph publishing corporation new delhi  na book condition new pp bookseller inventory   more information about this seller  ask bookseller a question  bookseller image christies march  modern  contemporary indian art christies used quantity available  from thecatalogstarcom ltd westbury united kingdom bookseller rating price us  convert currency shipping us  from united kingdom to usa destination rates  speeds item description book condition marked christies  new york sale title  modern  contemporary indian art sale date  th march  no of lots   no of pages   illustrated in colour index adimoolam k m am k i baij u k barwe i bendre n s bhattacharjee b bose n broota r chakravarty j chandra a chowdhury j claessen g daraniyagala j p das a das j das s dhawan r gaitonde v s gangooly j p goud l gujral s gupta s haloi g husain m f husain o kallat j kar s keyt g khakhar b khanna k kumar i p malani n mazumdar c mehta t menon a mistry d mukherjee m nail s natjsli i padamsee a panda j parekh m parthan b prabha b pyne g ray s d raza s h reddy r roy j roy s santhosh t v santosh g r sen p sheikh g m singh a singh p souza f n subramanyan k g sundaram v swaminathanj zarina weight g bookseller inventory   more information about this seller  ask bookseller a question  stock image c programming for scientists and engineers with applications carol a zieglerrama n reddy published by jones  bartlett india private limitedviva books  isbn   isbn   new softcover first edition quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description jones  bartlett india private limitedviva books  softcover book condition new first edition c is a favored and widely used programming language particularly within the fields of science and engineering c programming scientists and engineers with applications guides readers through the fundamental as well as the advanced concepts of the c programming language as it applies to solving engineering and scientific problems ideal for readers with no prior programming experience this text provides numerous sample problems and their solutions in the areas of mechanical engineering electrical engineering heat transfer fluid mechanics physics chemistry and more it begins with a chapter focused on the basic terminology relating to hardware software and problem definition and solution from there readers are quickly brought into the key elements of c and will be writing their own code upon completion of chapter  concepts are then gradually built upon using a strong structured approach with syntax and semantics presented in an easyto understand sentence format readers will find c programming for scientists and engineers with applications to be an engaging userfriendly introduction to this popular language key features include complete solutions with documentation code input and output are included at the end of each chapter and have been thoroughly run and tested pointers and dynamic pointers are presented in depth with sample code and complete endof chapter solutions input and output are presented in several ways including standard inputoutput and file inputoutput provides an early introduction of modular programming concepts and functions instructors resources include an instructors manual with solutions to all review and endofchapter exercises contents chapter  introduction to computers and programming concept of computers and computer systems hardware components and functions  software components and functions  integration of hardware and software  review questions  modular programming modular design  structure charts  functional modules  review questions  algorithms and program development concept of an algorithm  concept of programs and data  procedure for problem analysis  solution design methodology  concept of structured programming  review questions  program processing  program coding  program compilation  program execution  program testing  program documentation  review questions  program processing environment computer system environment  programming environment  review question  samples of algorithms resistance and voltage of a parallel circuit  volume of a sphere  square root approximation  total pressure of gaseous mixture  mass flow rate of air through pipes  chapter summary  exercises chapter  basic elements of the c programming language introduction to c structured language  procedural language  statically typed language  review questions  constants and variables character set  identifiers  builtin data types  derived data types  pointer and pointer variables  review questions  arithmetic operations and expressions arithmetic operators and operations  arithmetic expressions  assignment statement  order of evaluations  use of parentheses  special operators  accuracy of computation  c libraries and functions  review questions  overview of implementation formatting of statements  formatting of a program  data design  review questions  first complete programs sample c programs  slope of a straight line  compression stress in a steel column  set of simultaneous equations  area of a scalene triangle  volume of sphere  chapter summary  exercises chapter input and output input and output functions formatted input and output functions  standard input function  standard output function  review questions  file input and output printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image widowhood in modern india pkb nayar published by br publishing corporation  isbn   isbn   new hardcover first edition quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description br publishing corporation  hardcover book condition new first edition this volume is a collection of selected papers of the first national seminar on widowhood in india organised recently by the trivandrumbased centre for gerontological studies it gives a fair picture of indian widows cutting across ethnic and regional barriers some of the papers trace the origin and development of widowhood practices in india some deal with special categories of widows like the brindaban widows war widows elderly widows tribal widows etc others deal with the loopholes in property rights of and other legal remedies for widows and yet others deal with the double standards of society in its attitude and behaviour towards widows the point that in spite of several social reforms and legal enactments the widows continue to suffer from social discrimination has been brought out in the book with authenticity as also the factors contributing to the malaise the problem assumes significance since  of the total women and  of married women in india are widows and this will make the content of this book specially significant to all concerned the selection of papers has been done with great care and as a result the reader can have a full view of the different dimensions of widowhood and their socioeconomic and psychological underpinnings from several points of view the book will have strong appeal to the policy maker social reformer and scholars of womens studies besides social scientists and social activists indeed all those concerned with the lot of a significant segment of the population the widows  who suffer from socially instituted but invidious and avoidable sufferings contents introduction  widowhood in indiapkb nayar  the institution of widowhood  a historical perspectivea suryakumari a  widowhood and the law in india  a sociological studyramola b joseph  sociocultural and religious linkages in the status of muslim widowam khan  historical and contemporary perspectives of widows in maharashtraa ramanamma and jitendra kumar gond  property rights of widows in rural maharashtra  a socioeconomic study of womens awareness of rights and access to justicekarine bates  status of widows in karnataka  historical account and analysis of present scenarion vighnesh bhatt  widows in tamil nadus gohilavaani  widowhood aging and institutional management  the case of punjabbalwinder arora  living on the edge  a study of war widowsraj mohini sethi  social exclusion of bengali widowsmita barman  social change among the high caste hindu widows in a metropolisnirupama vyas  christian widowhood in keralaceline augustine  widowheaded households in kerala  a sociopsychological studyb sobha nair  widowhood in andhra pradeshd usha rani v sreedevi mvs reddy and pj reddy  tribal widows of gujarat  problems and their solutionsjc patel printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image marketing and service management bcom st sem bangalore  nd sem tumkur uni murthy rn nagaraja kn reddy cm eswara sure published by kalyani publishers  isbn   isbn   new first edition quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description kalyani publishers  book condition new st bookseller inventory  kp more information about this seller  ask bookseller a question  stock image the independence day association of harlem celebration  classic reprint paperback unknown author published by forgotten books united states  isbn  x isbn   new paperback quantity available  from the book depository london united kingdom bookseller rating print on demand price us  convert currency shipping free from united kingdom to usa destination rates  speeds item description forgotten books united states  paperback book condition new language english  brand new book  print on demand excerpt from the independence day association of harlem celebration  it is earnestly hoped that you will make a special effort to be present and that we may show that the patriotic memories and glories associated with the nation s birthday have not yet faded out a large and enthusiastic meeting was held resulting in the determination to make an effort for the purpose of redeeming at least one section of our city from the reproach which the neglect to celebrate our country s birthday was bringing upon our people the independence day association of harlem was formed with capt a m underhill as president j h bogart as secretary and a n brockway m d as treasurer an executive committee was organized by the election of charles w dayton as chairman hon henry p mcgown as vicechairman and capt william c reddy as secretary about the publisher forgotten books publishes hundreds of thousands of rare and classic books find more at this book is a reproduction of an important historical work forgotten books uses stateoftheart technology to digitally reconstruct the work preserving the original format whilst repairing imperfections present in the aged copy in rare cases an imperfection in the original such as a blemish or missing page may be replicated in our edition we do however repair the vast majority of imperfections successfully any imperfections that remain are intentionally left to preserve the state of such historical works bookseller inventory  apc more information about this seller  ask bookseller a question  stock image the independence day association of harlem celebration  classic reprint paperback unknown author published by forgotten books united states  isbn  x isbn   new paperback quantity available  from book depository hard to find london united kingdom bookseller rating price us  convert currency shipping free from united kingdom to usa destination rates  speeds item description forgotten books united states  paperback book condition new language english  this book usually ship within  business days and we will endeavor to dispatch orders quicker than this where possible brand new book excerpt from the independence day association of harlem celebration  it is earnestly hoped that you will make a special effort to be present and that we may show that the patriotic memories and glories associated with the nation s birthday have not yet faded out a large and enthusiastic meeting was held resulting in the determination to make an effort for the purpose of redeeming at least one section of our city from the reproach which the neglect to celebrate our country s birthday was bringing upon our people the independence day association of harlem was formed with capt a m underhill as president j h bogart as secretary and a n brockway m d as treasurer an executive committee was organized by the election of charles w dayton as chairman hon henry p mcgown as vicechairman and capt william c reddy as secretary about the publisher forgotten books publishes hundreds of thousands of rare and classic books find more at this book is a reproduction of an important historical work forgotten books uses stateoftheart technology to digitally reconstruct the work preserving the original format whilst repairing imperfections present in the aged copy in rare cases an imperfection in the original such as a blemish or missing page may be replicated in our edition we do however repair the vast majority of imperfections successfully any imperfections that remain are intentionally left to preserve the state of such historical works bookseller inventory  lie more information about this seller  ask bookseller a question  stock image environmental education problems and prospects db raoramesh ghanta published by discovery publishing house pvt ltd  isbn   isbn   new hardcover quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description discovery publishing house pvt ltd  hardcover book condition new man as a part and parcel of the environment has to recognize the role and importance of environment in order to protect it and to get protection from it for this he needs environmental education as the environmental education is the process of recognizing values and classifying concepts in order to develop skills and attitudes necessary to understand and appreciate the interrelatedness of man his culture and his biophysical surrounding and as it also entails practice in decision making and self formulation of a code of behaviour about issues concerning environmental quality recognizing the importance of environmental education the editors have included the articles on various issues concerned to environment and environmental education which will make the readers aware of the need of the protection of nature and its resources in order to save the mankind from the natural and manmade disasters the diversified views discussions strategies and information on environmental education will make the readers respond to the environmental issues this book will be of great use to scientists teachers students researchers and social service activists contents  environmental education the need and the challengeg ramesh  environmental educationp mohan rao  environmental education  the need of the hourbsv dutt  environmental education  the need of the dayavvs swamy  environmental education  concept of environment and ecosystem in relation to menm vikram reddy  environmental education and womeng vijaya lakshmi  environmental pollutiony sridevi and vv vardhani  environmental pollutionbv appa rao  marine pollutionvv vardhani  ms y sridevi  natural resources and their conservationg vijaya laksmi  environmental crisis and conservationn ramnath kishan  biodiversity  the concept need and importancekaiser jamil  biodiversity  its need and importancemrs deepika  environmental management and protectiony prameela devi  environmental degradation  health implicationsvijaya lakshmi  prof a satyavati  environment and healthg vijaya lakshmi  urbanization environment and educationcps chauhan  environmental impact assessmenty anjanajulu  environmental education at the school levelbimal charan swain  raja lakshmi das  environmental education and the curriculummarlow ediger  environmental education  curricular changesvbb sarma  environmental education  behavioural concerns and curriculum developmenta rama krishna  teaching learning strategies in environmental educationd bhaskara rao  environmental education  training a primary teacherpv seetha rama raju  water pollution  strategies in educationt murunalini  the new gardenr ranga rao  humanizing education through environmental issuesjs grewal  the man inside is the environment outsideg aruna  un and environment protecting the global environment  undp and the environment  who health and environment action  unesco and environment  rio declaration on environment and development  protection of the atmosphere  promoting education public awareness and training  nonlegally binding authoritative statement of principles for a global consensus on the management conservation and sustainable development of all types of forests  earth summit    a recession of spiritn lakshman  yet another environment dayk sharma  environmental citizenship printed pages  bookseller inventory   more information about this seller  ask bookseller a question  stock image principles of management fifth edition pc tripathipn reddy published by tata mcgrawhill education pvt ltd  isbn   isbn   new softcover quantity available   from bookvistas new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description tata mcgrawhill education pvt ltd  softcover book condition new th or later edition principles of management by tripathi and reddy is a well defined textbook which gives a basic knowledge about managerial functions in the most organised and useful way the organisation of the book has a management function approach after reading this book the students would understand what management is and how it is applied to various functions across the organisation this new edition has been comprehensively updated keeping in view the current trends in management pedagogically the book has been enriched with more features such as learning objectives cases at the end of the chapters project work boxed items encapsulating latest happenings in the field table of contents preface to the fifth edition preface to the first edition chapter  nature and functions of management chapter  development of management thought chapter  social responsibilities of business chapter  planning chapter  decisionmaking chapter  business forecasting and operations research chapter  organisation chapter  authority delegation and decentralisation chapter  coordination chapter  informal organisation chapter  staffing chapter  training and development chapter  performance management chapter  compensation plans chapter  direction and supervision chapter  communication chapter  leadership chapter  managerial control chapter  organisational change chapter  management of organisational conflict and power politics chapter  organisational climate or culture oc printed pages  bookseller inventory   more information about this seller  ask bookseller a question  the oxford companion to economics in india revised edition kaushik basu ed published by oxford university press new delhi india  new paperback quantity available   from sanctum books new delhi delhi india bookseller rating price us  convert currency shipping us  from india to usa destination rates  speeds item description oxford university press new delhi india  paperback book condition new revised edition in todays complex and fast evolving environment understanding indias economy is not just an intellectual challenge but with the country emerging as a major global player also a requirement this unique volume the first comprehensive resource of its kind on the contemporary indian economy aims to address this need culled from the collective wisdom and experience of over  distinguished contributors that include economists business leaders policymakers and analysts the companion covers the evolution of the indian economy from relative obscurity to an emergent global force the more than  entries span the recent cover stories of indias high growth leadership in software and information technology and outsourcing success and also document the backwatersthe widespread poverty farmer suicides child labour and the large and impoverished informal sector that houses a majority of indias labour force the revised edition a testimonial to the dynamism that epitomizes the indian economy includes several new topics that have grown in significance since the first edition was planned and several revised entries on topics that have undergone rapid transformation during the short time since the first edition was written contributors ak shiva kumar a vaidyanathan abhijit v banerjee abhirup sarkar aditya bhattacharjea ajay mahal ajay shah ajit k ghose ajit mishra alaka malwade basu amaresh bagchi amartya sen amitabh kundu amitava bose amiya kumar bagchi amrita dhillon anandita philipose anindita pujari anindya sen anirvan banerji anjini kochar anup kumar sinha anuradha bhasin arindam banik arindam dasgupta arjun sengupta arkadev chatterjea arnab basu arvind panagariya arvind subramanian arvind virmani asani sarkar ashima goyal ashok v desai ashok guha ashok gulati ashok kotwal ashok lahiri ashok mitra ashwini deshpande asim k dasgupta basudeb chaudhuri bharat ramaswami bhargavi rao bhaskar dutta bibek debroy bimal jalan bina agarwal bpr vithal charan singh cnr rao c rammanohar reddy d narayana david e bloom deb kusum das deena khatkhate deepak nayyar devesh kapur dhushyanth raju dilip mookherjee dilip m nachane dilip subramanian dipjyoti majumdar divya minisandram e somanathan esther duflo g balachandran gary s fields gayatri ambika menon gurcharan das hèlène chevrousèvèrac hiranya mukhopadhayay ignatius chithelen ila patnaik indrani gupta ira n gang isher judge ahluwalia jaivir singh jayashree watal jayati sarkar jean dreze jeemol unni jeffrey hammer jishnu das jugnu bagga kl krishna k navaneetham ks krishnaswamy k seeta prabhu kaivan munshi kala seetharam sridhar kameshwari shankar kanhaiya singh kanti bajpai karthik muralidharan kaushik ranjan bandyopadhyay laveesh bhandari ms swaminathan madhura swaminathan maitreesh ghatak mandar p oak mausumi das medha malik kudaisya mihir pandey mihir rakshit milind kandlikar mirai chatterjee mohammed zakaria siddiqui monica das gupta montek s ahluwalia mrinal datta chaudhuri mukesh anand mukesh eswaran mukesh gulati nr narayana murthy nagesh kumar nancy chau narendra jadhav nirvikar singh nitin desai omkar goswami p chidambaram pami dua pankaj chandra partha ray parthasarathi shome payal malik pc kesavan prabhat patnaik pradip k bhaumik pranab bardhan prasanta k pattanaik pratap bhanu mehta prital sailesh kadakia pulin nayak puran b mongia r nagaraj ra mashelkar rk pachauri rs deshpande rafiq dossani raghav gaiha rajesh chakrabarti rajnish mehra ram singh ramprasad sengupta ranjan ray rashmi banga ratan tata ravi kanbur reema nanavaty renana jhabvala ritu anand roger jeffery rohini pande rohini somanathan ronald j herring ruchira bhattamishra rupa chanda s neelakantan s subramanian s mahendra dev sl rao saibal ghosh sajal lahiri sanjay banerji satya priya bookseller inventory   more information about this seller  ask bookseller a question  results    of       › sort by  author az author za bookseller rating highest price lowest price lowest total price most recently listed relevance beta title az title za year of publication ascending year of publication descending create a want tell us what youre looking for and once a match is found well inform you by email create a want booksleuth cant remember the title or the author of a book our booksleuth is specially designed for you visit booksleuth help with search search tips glossary of terms set your own search preferences mobile view available not available × drreddy’s in india drreddy’s in india portfolio top brands biosimilars differentiated products otc list therapy areas oncology pain management cardiovascular diabetes dental nephrology urology programs for doctors for patients drfhe people working with drreddys careers contact us medical information india drreddy’s in india portfolio programs people contact us medical information reporting of adverse events drreddy’s in india dr reddy’s commenced its generics business in india in  and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality affordable and innovative medicines across therapy areas portfolio spanning wide range of therapy and disease areas over the years the company has significantly grown its portfolio of products across mass and specialty therapies today our portfolio has over  products covering the whole spectrum of disease areas spanning gastroenterology oncology pain management cardiovascular dermatology urology nephrology rheumatology and diabetes seven of our brands are listed in “top of the indian pharma market” and many others hold leadership positions in their respective categories ensuring that medicines are available when needed dr reddy’s has built a robust field force driven by the zeal to make a difference in the lives of patients the member strong team network connects with more than three lakh doctors on a regular basis to ensure that quality medicines we make are available for patients across the length and breadth of the country their efforts are backed by our unique inventory management system viva viable vision to ensure that the medicines are available for patients when they need it going beyond the pill to address patient needs as a company we have progressively transitioned from being a maker of molecules to a provider of medicines along the way we developed a deeper empathy for the needs of patients and their caregivers this has impelled dr reddy’s as an organization to go beyond medicines and leverage our capabilities to meet some of these unmet patient needs our purple health initiative in india aims at taking patient care beyond the pill focusing our efforts in four areas disease awareness and convenient diagnosis access to medicines better therapy experience adherence to therapy drreddy’s in india drreddy’s in india portfolio top brands biosimilars differentiated products otc list therapy areas oncology pain management cardiovascular diabetes dental nephrology urology programs for doctors for patients drfhe people working with drreddys careers contact us medical information india drreddy’s in india portfolio programs people contact us medical information reporting of adverse events drreddy’s in india dr reddy’s commenced its generics business in india in  and is today a trusted name in the healthcare industry consistently serving the needs of millions of patients with high quality affordable and innovative medicines across therapy areas portfolio spanning wide range of therapy and disease areas over the years the company has significantly grown its portfolio of products across mass and specialty therapies today our portfolio has over  products covering the whole spectrum of disease areas spanning gastroenterology oncology pain management cardiovascular dermatology urology nephrology rheumatology and diabetes seven of our brands are listed in “top of the indian pharma market” and many others hold leadership positions in their respective categories ensuring that medicines are available when needed dr reddy’s has built a robust field force driven by the zeal to make a difference in the lives of patients the member strong team network connects with more than three lakh doctors on a regular basis to ensure that quality medicines we make are available for patients across the length and breadth of the country their efforts are backed by our unique inventory management system viva viable vision to ensure that the medicines are available for patients when they need it going beyond the pill to address patient needs as a company we have progressively transitioned from being a maker of molecules to a provider of medicines along the way we developed a deeper empathy for the needs of patients and their caregivers this has impelled dr reddy’s as an organization to go beyond medicines and leverage our capabilities to meet some of these unmet patient needs our purple health initiative in india aims at taking patient care beyond the pill focusing our efforts in four areas disease awareness and convenient diagnosis access to medicines better therapy experience adherence to therapy our story our story brand heritage our founder milestones an unfinished agenda leadership board of directors management council featured stories our products business porfolio generics overthecounter apis biologics differentiated formulations services quality therapeutic focus our science research philosophy development streams generics apis biologics differentiated formulations capabilities our people life at drreddys comeback careers for women our citizenship patients healthcare professionals community our approach education livelihoods healthcare change makers planet commitment to the planet initiatives carbon footprint affiliates dr reddy’s foundations partners sustainability investors reports and filings annual reports quarterly reports sec filings nd annual general meeting moa and aoa presentations presentations earnings call shares share price stock updates equity  dividend history unpaid  unclaimed dividend analyst coverage shareholding pattern share transfer information buyback details of shares for transfer to iepf may  notice pursuant to iepf rules  details of shares for transfer to iepf august  notice pursuant to iepf rules  aug  notice on agm  evoting infotmation governance internal control systems committees of the board code of business conduct and ethics cobe ombudsperson policy compliance with nyse information to stakeholders corporate governance reports policies and documents investor services statutory communication shareholder’s contacts shareholder information investor meeting details media press releases media kit dr reddys in the news partners prospective partners post an enquiry login for current partners canada dr reddys in canada our products medical information contact us australia dr reddys in australia our products contact us china dr reddys in china our products contact us germany dr reddys in germany our products contact us india drreddy’s in india portfolio top brands biosimilars differentiated products otc list therapy areas programs for doctors for patients drfhe people working with drreddys careers contact us medical information new zealand dr reddys in new zealand contact us contact us global locations key contacts medical information our story  years countries peopleone purpose brand heritage leadership featured stories featured stories dr reddy’s listed on the dow jones sustainability indices  at dr reddys we are always mindful of the triple bottom line  pemore acting with dynamism to bring good health how the cps team pulled out all the stops to make critical more small steps to a robust healthcare system efficient healthcare delivery is not only about molecules or medicimore a pact of good health for cancer patients additionally the app also contains information on the most updatemore leveraging technology to bring good health cancer is a growing phenomenon worldwidemore a new direction to improved cancer care with the changing pace of life diseases like cancer are becoming imore making good health available all the time access to good health is not only about the price of medicines butmore the right prescription for patientcentricity the health ecosystem is changing more an easytoswallow remedy for diabetes india is facing a diabetes epidemic with  million confirmed diabemore x life at drreddys our story brand heritage our founder milestones an unfinished agenda leadership board of directors management council featured stories our products business porfolio generics overthecounter apis biologics differentiated formulations services quality therapeutic focus our science research philosophy development streams generics apis biologics differentiated formulations capabilities our people life at drreddys comeback careers for women our citizenship patients healthcare professionals community our approach education livelihoods healthcare change makers planet commitment to the planet initiatives carbon footprint affiliates dr reddy’s foundations partners sustainability investors reports and filings annual reports quarterly reports sec filings nd annual general meeting moa and aoa presentations presentations earnings call shares share price stock updates equity  dividend history unpaid  unclaimed dividend analyst coverage shareholding pattern share transfer information buyback details of shares for transfer to iepf may  notice pursuant to iepf rules  details of shares for transfer to iepf august  notice pursuant to iepf rules  aug  notice on agm  evoting infotmation governance internal control systems committees of the board code of business conduct and ethics cobe ombudsperson policy compliance with nyse information to stakeholders corporate governance reports policies and documents investor services statutory communication shareholder’s contacts shareholder information investor meeting details media press releases media kit dr reddys in the news partners prospective partners post an enquiry login for current partners canada dr reddys in canada our products medical information contact us australia dr reddys in australia our products contact us china dr reddys in china our products contact us germany dr reddys in germany our products contact us india drreddy’s in india portfolio top brands biosimilars differentiated products otc list therapy areas programs for doctors for patients drfhe people working with drreddys careers contact us medical information new zealand dr reddys in new zealand contact us contact us global locations key contacts medical information our people life at drreddys comeback careers for women life at drreddys empowered people exceptional results talented and capable people have played a major role in powering and defining the growth of dr reddys over the last three decades they have been supported by an enabling environment that buoys individual talent while fostering teamwork and the creation of shared success we believe that when people with diverse skills are bound together by a common purpose and value system they can make magic as a member of our team you will make the world a healthier place every day patients across the world trust us with their health we have earned this trust through personal integrity product quality and organizational transparency we invite you to become a part of a team that does not believe in compromises in the pursuit of shortterm success become part of a team that cares we are committed to each others safety and wellbeing in each of our plants work sites offices and out in the field our people believe in taking care of each other and collectively we are committed to taking care of the communities where we operate enjoy professional freedom to create impact we will provide the space and freedom for you to experiment innovate and put your talents to work you will have the opportunity to unleash your potential and create impact in any area you happen to work learn continually excel and grow we work at the frontiers of knowledge and irrespective of the field you choose you will be exposed to some of the finest thinking in the world you will be actively supported in your development and have access to leadingedge learning resources expect to be treated with respect we believe in respecting every individual regardless of position you will be heard and will have the opportunity to express your opinion you will have the freedom to interact with any of our leaders in turn your colleagues will expect you to be equally accessible and respectful current openings in  india usa everyone here is valued for the contributions they make sarah warren dr reddys is an organisation that really cares for people ajay prakash dhanak the chairman speaking to us made us feel respected richard heri i come in everyday because i know my work makes a difference krishna venkatesh x